
<html lang="en"     class="pb-page"  data-request-id="e9d8277b-7a4d-41e3-b400-f3bc3975d5a6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-8;wgroup:string:ACHS website Group;article:article:10.1021/jm901783v;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Zecheng  Chen" /></meta><meta name="dc.Creator" content="Aranapakam M.  Venkatesan" /></meta><meta name="dc.Creator" content="Christoph M.  Dehnhardt" /></meta><meta name="dc.Creator" content="Semiramis  Ayral-Kaloustian" /></meta><meta name="dc.Creator" content="Natasja  Brooijmans" /></meta><meta name="dc.Creator" content="Robert  Mallon" /></meta><meta name="dc.Creator" content="Larry  Feldberg" /></meta><meta name="dc.Creator" content="Irwin  Hollander" /></meta><meta name="dc.Creator" content="Judy  Lucas" /></meta><meta name="dc.Creator" content="Ker  Yu" /></meta><meta name="dc.Creator" content="Fangming  Kong" /></meta><meta name="dc.Creator" content="Tarek S.  Mansour" /></meta><meta name="dc.Description" content="Significant evidence suggests that deregulation of the PI3K/Akt pathway is important in tumor progression. Mechanisms include loss of function of the tumor suppressor PTEN and high frequency of mut..." /></meta><meta name="Description" content="Significant evidence suggests that deregulation of the PI3K/Akt pathway is important in tumor progression. Mechanisms include loss of function of the tumor suppressor PTEN and high frequency of mut..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 24, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901783v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901783v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901783v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901783v" /></link>
        
    
    

<title>Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901783v" /></meta><meta property="og:title" content="Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0008.jpeg" /></meta><meta property="og:description" content="Significant evidence suggests that deregulation of the PI3K/Akt pathway is important in tumor progression. Mechanisms include loss of function of the tumor suppressor PTEN and high frequency of mutation of the PI3K p110α isoform in human malignancies. This connection between PI3K and tumor genesis makes PI3K a promising target for cancer treatment. A series of 4-morpholinopyrrolopyrimidine derivatives were synthesized and evaluated as inhibitors of PI3Kα and mTOR, leading to the discovery of PI3Kα selective inhibitors (e.g., 9) and dual PI3Kα/mTOR kinase inhibitors (e.g., 46 and 48). PI3Kα/mTOR dual inhibitors demonstrated inhibition of tumor cell growth in vitro and in vivo and caused suppression of the pathway specific biomarkers [e.g., the phosphorylation of Akt at Thr308 (T308) and Ser473 (S473)] in the human breast cancer cell line MDA361. In addition, compound 46 demonstrated good in vivo efficacy in the MDA361 human breast tumor xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901783v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901783v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901783v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901783v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901783v&amp;href=/doi/10.1021/jm901783v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3169-3182</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901776q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9017866" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zecheng++Chen">Zecheng Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aranapakam+M.++Venkatesan">Aranapakam M. Venkatesan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph+M.++Dehnhardt">Christoph M. Dehnhardt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Semiramis++Ayral-Kaloustian">Semiramis Ayral-Kaloustian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natasja++Brooijmans">Natasja Brooijmans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Mallon">Robert Mallon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry++Feldberg">Larry Feldberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irwin++Hollander">Irwin Hollander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judy++Lucas">Judy Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ker++Yu">Ker Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fangming++Kong">Fangming Kong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+S.++Mansour">Tarek S. Mansour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Chemical Sciences</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Oncology</span></div><div class="aff-info" id="affc"><span class="aff-symbol">§</span> <span class="aff-text">Analytical Quality Sciences</span></div><div class="aff-info" id="wr"><span class="aff-text">Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 1-845-602-8341. Fax: 1-845-602-5561. E-mail: <a href="/cdn-cgi/l/email-protection#fe9d969b9084cfbe89879b8a96d09d9193"><span class="__cf_email__" data-cfemail="b8dbd0ddd6c289f8cfc1ddccd096dbd7d5">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#beddd6dbd0c4dbddd6dbd0d9fed6d1cad3dfd7d290ddd1d3"><span class="__cf_email__" data-cfemail="2e4d464b40544b4d464b40496e46415a434f4742004d4143">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901783v&amp;href=/doi/10.1021%2Fjm901783v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3169–3182</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 24, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 December 2009</li><li><span class="item_label"><b>Published</b> online</span>24 March 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901783v" title="DOI URL">https://doi.org/10.1021/jm901783v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3169%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZecheng%2BChen%252C%2BAranapakam%2BM.%2BVenkatesan%252C%2BChristoph%2BM.%2BDehnhardt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D8%26contentID%3Djm901783v%26title%3DSynthesis%2Band%2BSAR%2Bof%2BNovel%2B4-Morpholinopyrrolopyrimidine%2BDerivatives%2Bas%2BPotent%2BPhosphatidylinositol%2B3-Kinase%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3182%26publicationDate%3DApril%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901783v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3781</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901783v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and SAR of Novel 4-Morpholinopyrrolopyrimidine Derivatives as Potent Phosphatidylinositol 3-Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zecheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Aranapakam&quot;,&quot;last_name&quot;:&quot;M. Venkatesan&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;M. Dehnhardt&quot;},{&quot;first_name&quot;:&quot;Semiramis&quot;,&quot;last_name&quot;:&quot;Ayral-Kaloustian&quot;},{&quot;first_name&quot;:&quot;Natasja&quot;,&quot;last_name&quot;:&quot;Brooijmans&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Mallon&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;Feldberg&quot;},{&quot;first_name&quot;:&quot;Irwin&quot;,&quot;last_name&quot;:&quot;Hollander&quot;},{&quot;first_name&quot;:&quot;Judy&quot;,&quot;last_name&quot;:&quot;Lucas&quot;},{&quot;first_name&quot;:&quot;Ker&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Fangming&quot;,&quot;last_name&quot;:&quot;Kong&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;S. Mansour&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3169-3182&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901783v&quot;},&quot;abstract&quot;:&quot;Significant evidence suggests that deregulation of the PI3K/Akt pathway is important in tumor progression. Mechanisms include loss of function of the tumor suppressor PTEN and high frequency of mutation of the PI3K p110α isoform in human malignancies. This connection between PI3K and tumor genesis makes PI3K a promising target for cancer treatment. A series of 4-morpholinopyrrolopyrimidine derivatives were synthesized and evaluated as inhibitors of PI3Kα and mTOR, leading to the discovery of PI3Kα selective inhibitors (e.g., 9) and dual PI3Kα/mTOR kinase inhibitors (e.g., 46 and 48). PI3Kα/mTOR dual inhibitors demonstrated inhibition of tumor cell growth in vitro and in vivo and caused suppression of the pathway specific biomarkers [e.g., the phosphorylation of Akt at Thr308 (T308) and Ser473 (S473)] in the human breast cancer cell line MDA361. In addition, compound 46 demonstrated good in vivo efficacy in the MDA361 human breast tumor xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901783v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901783v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901783v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901783v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901783v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901783v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901783v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901783v&amp;href=/doi/10.1021/jm901783v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901783v" /></input><a href="/doi/pdf/10.1021/jm901783v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901783v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901783v%26sid%3Dliteratum%253Aachs%26pmid%3D20334367%26genre%3Darticle%26aulast%3DChen%26date%3D2010%26atitle%3DSynthesis%2Band%2BSAR%2Bof%2BNovel%2B4-Morpholinopyrrolopyrimidine%2BDerivatives%2Bas%2BPotent%2BPhosphatidylinositol%2B3-Kinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D8%26spage%3D3169%26epage%3D3182%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Significant evidence suggests that deregulation of the PI3K/Akt pathway is important in tumor progression. Mechanisms include loss of function of the tumor suppressor PTEN and high frequency of mutation of the PI3K p110α isoform in human malignancies. This connection between PI3K and tumor genesis makes PI3K a promising target for cancer treatment. A series of 4-morpholinopyrrolopyrimidine derivatives were synthesized and evaluated as inhibitors of PI3Kα and mTOR, leading to the discovery of PI3Kα selective inhibitors (e.g., <b>9</b>) and dual PI3Kα/mTOR kinase inhibitors (e.g., <b>46</b> and <b>48</b>). PI3Kα/mTOR dual inhibitors demonstrated inhibition of tumor cell growth in vitro and in vivo and caused suppression of the pathway specific biomarkers [e.g., the phosphorylation of Akt at Thr308 (T308) and Ser473 (S473)] in the human breast cancer cell line MDA361. In addition, compound <b>46</b> demonstrated good in vivo efficacy in the MDA361 human breast tumor xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphatidylinositol-3-kinases (PI3Ks<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: PI3K, phosphatidylinositol 3-kinase; mTOR, mammalian target of rapamycin; Akt, protein kinase B; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PTEN, phosphatase and tensin homologue; RTK, receptor tyrosine kinase; GPCRs, G-protein-coupled receptors; PDK1, 3-phosphoinositide-dependent kinase 1; S, serine; T, threonine; ATP, adenosine 5′-triphosphate; Her2+, human epidermal growth factor receptor 2+; ELISA, enzyme-linked immunosorbent assay; DELFIA, dissociation-enhanced lanthanide fluorescent immunoassay.</p></div> are lipid kinases that catalyze phosphorylation of the 3-hydroxy position of PIP2 (phosphatidylinositol 4,5-diphosphate) to PIP3 (phosphatidylinositol 3,4,5-triphosphate), an important second messenger modulating activity of the PI3K downstream effectors Akt and mTOR. The consequences of biological activation of Akt include tumor progression, proliferation, survival, growth, invasion, angiogenesis, and metastasis. Significant evidence suggests that the PI3K/Akt pathway is deregulated in many human cancers.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PI3Ks are divided into three classes (I, II, and III) based on differences in sequence homology, substrate preference, and function.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The class I PI3Ks are heterodimers consisting of a catalytic subunit and a regulatory subunit. The catalytic subunits of class I PI3Ks include four isoforms: p110α, p110β, p110δ, and p110γ, encoded by four distinct genes termed <i>pik3ca</i>, <i>pik3cb</i>, <i>pik3cd</i>, and <i>pik3cg</i>, respectively. The class I PI3Ks are further divided into class IA and IB subgroups based on different regulatory subunits and activation mechanisms. Class IA includes three isoforms PI3Kα, PI3Kβ, and PI3Kδ activated by receptor tyrosine kinases (RTKs) and small G-protein-coupled receptors (GPCRs), while class IB has only one isoform, PI3Kγ, primarily activated by GPCRs. The <i>pik3ca</i> gene, which encodes the catalytic subunit of PI3Kα, is mutated and overexpressed in a wide range of human cancers, including breast, ovarian, colorectal, and brain tumors.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> In addition, the activation of the PI3K pathway is negatively regulated by dual phosphatase PTEN, and persistent activation of PI3K and loss of PTEN function often coexist in various cancers. All these factors provide strong evidence for the importance of the PI3K pathway in cancer.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a> Therefore, the significant connection between PI3K, in particular PI3Kα, with tumor genesis makes PI3Kα an attractive target for development of anticancer drugs.</div><div class="NLM_p">To date, several small molecule PI3K inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have been reported.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23">(12-23)</a> LY294002 (<b>1a</b>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and Wortmannin (<b>1b</b>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> have been extensively studied as PI3K inhibitors; however, their toxicity and poor physicochemical properties limited their potential therapeutic use.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of PI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Recently an imidazo[4,5-<i>c</i>]quinoline derivative, NVP-BEZ235 (<b>1c</b>), was reported by Novartis as a pan-PI3K/mTOR dual inhibitor.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Compound <b>1c</b> was shown to block the activation of the PI3K pathway and potently inhibit cell proliferation, causing G1 phase cell cycle arrest, and is currently in phase I/II clinical trials as an anticancer agent. Compound PI-103 (<b>1d</b>), a pyrido[3′,2′:4,5]furo[3,2-<i>d</i>]pyrimidine derivative, was equipotent against PI3Kα and PI3Kβ with an IC<sub>50</sub> of 4 nM and was selective over other tested protein kinases.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Genentech recently reported the thieno[3,2-<i>d</i>]pyrimidine derivative GDC-0941 (<b>1e</b>), a potent and orally bioavailable inhibitor of PI3K, in phase I clinical trials for the treatment of cancer. Notably, compound <b>1e</b> was equipotent against wild type PI3Kα and two common PI3Kα mutants (E545K and H1047R) with an IC<sub>50</sub> of 3 nM.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As part of our ongoing research on a variety of fused-pyrimidine scaffolds,<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> we now report the synthesis and biological evaluation of novel 4-morpholinopyrrolopyrimidine derivatives as potent PI3Kα inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic route for the preparation of 4-morpholinopyrrolo[3,2-<i>d</i>]pyrimidine derivatives is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The starting material 2,4-dichloro-6-methyl-5-nitropyrimidine (<b>2</b>) was treated with morpholine to give the corresponding 4-morpholino substituted intermediate <b>3</b>, which was reacted with different boronic acids or esters under Suzuki conditions to provide the corresponding 2-aryl substituted products. Reaction with 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (DMF·DMA) to form the corresponding enamine intermediate followed by the reductive cyclization under catalytic hydrogenation conditions gave the desired 5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidines <b>4</b>−<b>7</b>. Mannich-type reaction of <b>4</b>, by heating with formaldehyde and different amines in acetic acid solution, proceeded smoothly to yield compounds <b>8</b> and <b>9</b> with water-solubilizing groups introduced at the C7 position. Protection of the hydroxyl group with TBS in <b>4</b> followed by alkylation at the N5 position and removal of the TBS group afforded <b>10</b>, which underwent the Mannich-type reaction to give <b>11</b>. Aldol-type reaction of <b>6</b> with piperidin-4-one followed by catalytic hydrogenation of the resulting double bond provided derivative <b>12</b>. Reductive amination of <b>12</b>, using appropriate aldehydes and NaCNBH<sub>3</sub>, gave compounds <b>13</b> and <b>14</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine (1.5 equiv), Et<sub>3</sub>N (3 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 6 h; (b) ArB(OH)<sub>2</sub> (1.5 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 110 °C/30 min, microwave; (c) DMF·DMA (excess), DMF, 110 °C/12−18 h; (d) 10% Pd/C, MeOH, room temp, 2−6 h; (e) formaldehyde (2 equiv), amines (3 equiv), HOAc, 60 °C/6 h; (f) TBSCl (1.2 equiv), imidazole (1.5 equiv), DMF, 80 °C/15 min, microwave; (g) CH<sub>3</sub>I (1.2 equiv), NaH (2 equiv), THF, room temp, 2 h; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 6 h; (i) 4-piperidone (2.5 equiv), KOH (5 equiv), MeOH, 66 °C/15 h; (j) 10% Pd/C, HCl, MeOH, 50 psi, room temp, 16 h; (k) ArCHO (1.5 equiv), ZnCl<sub>2</sub> (1.5 equiv), NaBH<sub>3</sub>CN (1.5 equiv), MeOH, room temp, 5 h.</p></p></figure><div class="NLM_p">The general synthetic routes used for the preparation of 4-morpholinopyrrolo[2,3-<i>d</i>]pyrimidine derivatives are outlined in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>−<a class="ref internalNav" href="#sch4" aria-label="4">4</a>. 7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diol (<b>15</b>) was prepared, following a known procedure,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> by condensing 6-aminouracil with chloroacetaldehyde. Chlorination of <b>15</b> by heating with POCl<sub>3</sub> followed by selective substitution with the morpholino group at the C4 position provided intermediate <b>16</b>. Suzuki coupling of <b>16</b> with different boronic acids gave compounds <b>17</b> and <b>18</b>. Alternatively, alkylation of <b>16</b> with 2-(dimethylamino)ethyl chloride, using Cs<sub>2</sub>CO<sub>3</sub> as base, gave intermediate <b>19</b>. Reaction of <b>19</b> with different boronic acids provided <b>20</b> and <b>21</b>. Suzuki reaction of <b>19</b> with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline provided <b>22</b>, which was converted to urea derivatives <b>23</b>−<b>28</b> by reaction with triphosgene followed by appropriate amines.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, 120 °C/30 min, microwave; (b) morpholine (1.5 equiv), Et<sub>3</sub>N (3 equiv), EtOH, room temp; (c) ArB(OH)<sub>2</sub> (1.5 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 150 °C/40 min, microwave; (d) 2-(dimethylamino)ethyl chloride (1.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (3 equiv), DMF, 80 °C/12 h; (e) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 M Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (f) triphosgene (0.6 equiv), Et<sub>3</sub>N (3 equiv), amines (3−5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2−6 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (b) triphosgene (0.6 equiv), Et<sub>3</sub>N (3 equiv), 4-aminopyridine (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (c) CF<sub>3</sub>CH<sub>2</sub>I (2 equiv for <b>30</b>) or (CH<sub>3</sub>O)<sub>2</sub>CHBr (2 equiv for <b>31</b>), Cs<sub>2</sub>CO<sub>3</sub> (1.2 equiv), DMF, 80 °C/12 h; (d) HCl, dioxane/H<sub>2</sub>O, 70 °C/12 h (e) amines (6 equiv), ZnCl<sub>2</sub> (2 equiv), NaBH<sub>3</sub>CN (2 equiv), MeOH, room temp, 12 h; (f) NaBH<sub>4</sub> (1.5 equiv), MeOH/THF, room temp, 2 h.</p></p></figure><div class="NLM_p">Conversion of intermediate <b>16</b> to the 4-pyridylurea analogue <b>29</b> was achieved by a two-step sequence, described above for the conversion of <b>19</b> to <b>23</b>−<b>28</b>. Alkylation of <b>16</b> provided analogues <b>30</b> and <b>31</b>, which were converted to the corresponding 4-pyridylurea derivatives <b>32</b> and <b>33</b>. Hydrolysis of the acetal group in <b>33</b>, under acidic conditions, gave the aldehyde <b>34</b>. Reductive amination of <b>34</b>, using different amines, provided compounds <b>35</b>−<b>39</b>. Alternatively, reduction of the aldehyde group in <b>34</b>, using NaBH<sub>4</sub>, gave the corresponding alcohol analogue <b>40</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">Suzuki reaction of the N7 substituted pyrrolo[2,3-<i>d</i>]pyrimidine intermediates <b>30</b> and <b>41</b> gave the corresponding anilines <b>42</b> and <b>43</b>. Treatment of <b>42</b> and <b>43</b> with methyl 4-isocyanatobenzoate, followed by hydrolysis of the resulting esters under basic conditions, gave the corresponding 4-ureidobenzoic acids <b>44</b> and <b>45</b>. Finally, coupling of the acids <b>44</b> and <b>45</b> with different amines afforded the desired 4-ureidobenzamide derivatives <b>46</b>−<b>52</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (b) methyl 4-isocyanatobenzoate (1.2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (c) 1 N NaOH (3 equiv), MeOH/THF, 70 °C/12 h; (d) amines (2 equiv), HOBt (1.5 equiv), EDCI (1.5 equiv), Et<sub>3</sub>N (2 equiv), THF, room temp, 12 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All final compounds <b>4</b>−<b>14</b>, <b>16</b>−<b>20</b>, <b>23</b>−<b>29</b>, <b>32</b>−<b>40</b>, and <b>46</b>−<b>52</b> were tested for in vitro potency in a PI3Kα fluorescence polarization format assay<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and mTOR in a dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) platform enzyme-linked immunosorbent assay (ELISA).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compounds that showed reasonable PI3Kα potency were selected for further evaluation in the cell growth inhibition assays against PC3 (prostate, PTEN mutant) and MDA-361 (breast, Her2+/PI3KCA [E545K] mutant) human tumor cell lines.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The lead compound <b>1f</b>, an imidazolopyrimidine derivative, was previously prepared as a potent PI3K inhibitor.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It exhibited good PI3Kα activity (IC<sub>50</sub> = 63 nM) and moderate cell potency against PC3 (IC<sub>50</sub> = 1.2 μM), but this compound had low solubility, poor metabolic stability, and poor exposure. Replacement of the imidazole ring in <b>1f</b> with a pyrrole ring led to a series of 4-morpholinopyrrolo[3,2-<i>d</i>]pyrimidines (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The effects on PI3Kα inhibitory activity of different substituents on the phenyl ring at C3 of the pyrrolo[3,2-<i>d</i>]pyrimidine core are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The 3-hydroxymethyl and 3-hydroxy analogues, <b>4</b> and <b>6</b>, showed equal potency against PI3Kα, comparable to that of <b>1f</b>. Removal of the hydroxyl group in <b>4</b> led to a significant decrease in potency for <b>5</b>. Replacement of the 3-OH group in <b>6</b> with a 3-NH<sub>2</sub> group resulted in about 100-fold loss in potency for <b>7</b>. The hydroxyl group in both <b>4</b> and <b>6</b> was found to be essential for PI3Kα activity, indicating that it should be involved in protein binding as demonstrated in other fused pyrimidine series.<a onclick="showRef(event, 'ref21 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref24 ref25">(21, 24, 25)</a> Introduction of water solubilizing groups (−CH<sub>2</sub>NR<sub>1</sub>R<sub>2</sub>) at the C7 position of <b>4</b> resulted in about a 3-fold increase in PI3Kα potency for <b>8</b> and <b>9</b>. Compound <b>9</b> showed very good selectivity (171-fold) for PI3Kα over mTOR. However, incorporating a piperidine ring at the C7 position of <b>6</b> led to a 5-fold decrease in PI3Kα potency for <b>12</b>. Methyl substitution at the N5 position of the pyrrolo[3,2-<i>d</i>]pyrimidine core was not tolerated and resulted in a significant loss in activity. The <i>N</i>-methyl substituted analogue <b>10</b> was about 30-fold less potent than the corresponding NH analogue <b>4</b>, while <b>11</b> was 200-fold less potent than the corresponding compound <b>9</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0002.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">PI3Kα</th><th class="colsep0 rowsep0" align="center">mTOR</th><th class="colsep0 rowsep0" align="center">PC3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">634</td><td class="colsep0 rowsep0" align="left">1234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">1625</td><td class="colsep0 rowsep0" align="left">2075</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1506</td><td class="colsep0 rowsep0" align="left">5000</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">355</td><td class="colsep0 rowsep0" align="left">1551</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7500</td><td class="colsep0 rowsep0" align="left">430</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">108</td><td class="colsep0 rowsep0" align="left">>3160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-pyrrolinyl</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">3600</td><td class="colsep0 rowsep0" align="left">>3160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1996</td><td class="colsep0 rowsep0" align="left">>4000</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-pyrrolinyl</td><td class="colsep0 rowsep0" align="left">4207</td><td class="colsep0 rowsep0" align="left">>4000</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-piperidinyl</td><td class="colsep0 rowsep0" align="left">354</td><td class="colsep0 rowsep0" align="left">5900</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1-benzyl-4-piperidinyl</td><td class="colsep0 rowsep0" align="left">340</td><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1-(4-F-benzyl)-4-piperidinyl</td><td class="colsep0 rowsep0" align="left">178</td><td class="colsep0 rowsep0" align="left">3650</td><td class="colsep0 rowsep0" align="left">1652</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The values are averages of at least two separate determinations with a typical variation of less than ±30%. ND: not determined.</p></div></div></div><div class="NLM_p">In the meantime, a series of 4-morpholinopyrrolo[2,3-<i>d</i>]pyrimidines were prepared by replacing the N5 of the imidazole ring in <b>1f</b> with “CH”. The effects of different substituents on the phenyl ring and the N7 position on enzyme and cell potency are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 2. <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0003.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα</th><th class="colsep0 rowsep0" align="center" char=".">mTOR</th><th class="colsep0 rowsep0" align="center" char=".">PC3</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL), pH 7.4</th><th class="colsep0 rowsep0" align="center" char=".">permeability (10<sup>−6</sup> cm/s)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">634</td><td class="colsep0 rowsep0" align="char" char=".">1234</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">205</td><td class="colsep0 rowsep0" align="char" char=".">1211</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">580</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">>800</td><td class="colsep0 rowsep0" align="char" char=".">691</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">>800</td><td class="colsep0 rowsep0" align="char" char=".">1181</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The values are averages of at least two separate determinations with a typical variation of less than ±30%.</p></div></div></div><div class="NLM_p">As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the 3-hydroxymethyl analogue <b>17</b> and the 3-hydroxyl analogue <b>18</b> maintained PI3Kα inhibitory activity comparable to that of <b>1f</b>. Introducing an amino side chain at N7 of <b>17</b> led to about a 2-fold increase in PI3Kα potency for <b>20</b>, while appending the same group on <b>18</b> led to a slight decrease in PI3Kα potency for <b>21</b>. Both analogues <b>20</b> and <b>21</b> exhibited much weaker potency against mTOR. In comparison with <b>1f</b>, all four analogues in this series showed comparable or improved cell potency against PC3. It was found that this series of analogues showed good permeability, as well as good solubility except for <b>18</b>.</div><div class="NLM_p">Recent studies showed that the phenolic group was found to be a metabolic liability due to glucuronidation.<a onclick="showRef(event, 'ref21 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref26">(21, 26)</a> Isosteres for the phenolic group were explored to achieve a metabolically stable clinical candidate.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, our own research teams have shown that incorporation of a urea appendage instead of the phenolic group in the fused pyrimidine core not only improved metabolic stability but also increased PI3Kα potency and cell potency.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Therefore, a series of 4-ureido analogues were prepared by replacing the 3-hydroxyl group on the phenyl ring, and their biological data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 3. <a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0004.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R/Ar</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα</th><th class="colsep0 rowsep0" align="center" char=".">mTOR</th><th class="colsep0 rowsep0" align="center" char=".">PC3</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL), pH 7.4</th><th class="colsep0 rowsep0" align="center" char=".">stability <i>T</i><sub>1/2</sub> (min),<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> rat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">634</td><td class="colsep0 rowsep0" align="char" char=".">1234</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">142</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">882</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">137</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">4-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">189</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">437</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The values are averages of at least two separate determinations with a typical variation of less than ±30%. ND: not determined.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Half-life of drug when incubating with rat liver microsomes.</p></div></div></div><div class="NLM_p">Among the various pyridyl substituted ureas, the 4-pyridylurea analogue <b>25</b> showed the best PI3Kα potency with an IC<sub>50</sub> of 8 nM, which is 8-fold more potent than the lead compound <b>1f</b>. In the meantime, mTOR potency was also dramatically increased (IC<sub>50</sub> = 2 nM for <b>25</b> versus 634 nM for <b>1f</b>). More importantly, this compound exhibited a significant improvement in cellular potency against PC3, which is 12-fold more potent than <b>1f</b> in the cell assay. For PI3Kα enzyme potency, the 3-pyridylurea analogue <b>24</b> was 2-fold less potent than the 4-pyridylurea analogue <b>25</b>, while the 2-pyridylurea analogue <b>23</b> was 18-fold less potent than <b>25</b>. The same trend was observed in their PC3 cell potency, with the order 4-pyridyl > 3-pyridyl > 2-pyridyl. The F-substitued phenylurea analogue <b>26</b> was 3-fold more potent against PI3Kα than <b>1f</b>; however, it was 3-fold less potent than the 4-pyridylurea analogue <b>25</b>. In comparison with the arylurea analogues, the alkylurea analogues <b>27</b> and <b>28</b> were much less potent against PI3Kα. As for their properties, these urea analogues showed better water solubility, yet no improvements were observed in microsome stability in rat when compared to <b>1f</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0005.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0006.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The values are averages of at least two separate determinations with a typical variation of less than ±30%. ND: not determined.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Half-life of drug when incubating with rat liver microsomes.</p></div></div></div><div class="NLM_p">Since the 4-pyridylurea analogue <b>25</b> showed the best in vitro profile in the series, we explored the effects of different substitutions at the N7 position for further optimization. The effects of the substitutions at N7 on PI3Kα activity and cellular activity are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>29</b>, with no substitution at N7, was less potent against PI3Kα than <b>25</b> (bearing a dimethylaminoethyl group). Introducing cyclic amino substituted ethyl goups at N7 resulted in a decrease in PI3Kα potency (<b>35</b>, <b>36</b>, and <b>38</b>), as well as cellular potency when compared to <b>25</b>. The same result was observed for analogue <b>37</b>, bearing an ethylenediaminoethyl group at the N7 position. Compound <b>39</b>, bearing a 2-piperazinylethyl group at N7, exhibited PI3Kα potency comparable to that of <b>25</b> but showed 23-fold less in cell potency against PC3. Replacement of the dimethylamino group in <b>25</b> with a hydroxy retained PI3Kα potency as well as PC3 cell potency for <b>40</b>. The acetal analogue <b>33</b> was slightly less potent in PI3Kα but more potent in cell for PC3 compared to <b>25</b>. In contrast to <b>33</b>, the aldehyde analogue <b>34</b> was more potent in enzyme for PI3Kα; however, it was 6-fold less potent in cell for PC3 compared to <b>25</b>. Compound <b>32</b>, with a triflouroethyl group at N7, showed a comparable potency against PI3Kα and a better PC3 potency relative to <b>25</b>. In terms of pharmaceutical properties, analogues <b>32</b> and <b>40</b> demonstrated improved microsomal stability; however, both compounds showed poor solubility at pH 7.4. Molecular modeling of analogue <b>40</b>, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, displays the crucial hydrogen bonding interactions, including the morpholino oxygen binding to the hinge region Val851 and the urea moiety binding to Asp810 and Lys802. It is observed that the pyridyl nitrogen is pointing away from the binding pocket toward the solvent front. Hence, a series of 4-ureidobenzamide derivatives with extended basic amino groups were prepared for further optimization.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling study of <b>40</b> (shown in turquoise for its skeleton) docked in PI3Kα homology model based on PI3Kγ crystal structures.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The assay results of 4-ureidobenzamide derivatives are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. In general, the 4-ureidobenzamide analogues possessed excellent enzyme potency against PI3Kα and mTOR, as well as high cell potency against PC3 and MDA361. Compound <b>46</b> was 11-fold more potent against PI3Kα and 9-fold more potent in cell against PC3 compared to <b>32</b>. Analogues <b>47</b>−<b>49</b> bearing different amide groups also showed excellent PI3Kα potency with IC<sub>50</sub> values ranging from 0.9 to 6 nM, as well as good cell potency against PC3 with IC<sub>50</sub> values ranging from 17 to 45 nM. Replacement of 2,2,2-trifluoroethyl group with ethyl at N7, resulted in compounds <b>50</b>−<b>52</b>, which also showed excellent PI3Kα potency and good cell potency against PC3 and MDA361. Most analogues in this series showed improved stability in rat and human liver microsomes, and compounds <b>46</b> and <b>48</b> showed good stability in nude mouse liver microsomes with <i>T</i><sub>1/2</sub> > 30 min. The solubility of these compounds were poor at physiological pH; however, it can be improved at pH 3.0 because of the presence of the basic amino groups in their molecules, as seen in examples for compounds <b>46</b>−<b>48</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 5. <a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0007.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα</th><th class="colsep0 rowsep0" align="center" char=".">mTOR</th><th class="colsep0 rowsep0" align="center" char=".">MDA361</th><th class="colsep0 rowsep0" align="center" char=".">PC3</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (Rat)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (Human)</th><th class="colsep0 rowsep0" align="center" char=".">sol.,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> pH 7.4</th><th class="colsep0 rowsep0" align="center" char=".">sol.,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> pH 3.0</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char="."><3.0</td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">23.0</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">26.5</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">27.0</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The values are averages of at least two separate determinations with a typical variation of less than ±30%. ND: not determined.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Half-life of drug when incubating with liver microsomes of the species shown.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Solubility in μg/mL.</p></div></div></div><div class="NLM_p">Analogues <b>46</b> and <b>48</b> were then assayed in vivo for their ability to suppress appropriate biomarkers. Inhibition of PI3Kα should result in suppression of the phosphorylation of Akt, particularly at T308. As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, analogues <b>46</b> and <b>48</b> suppressed phosphorylation of Akt T308 in MDA361 breast tumor cells for up to 8 h when administered 25 mpk, iv, in nude mouse. The actin (control protein) signal was unaffected by <b>46</b> and <b>48</b>. Both compounds also inhibited phosphorylation of Akt S473 and S6K, substrates of mTOR, indicating that they are PI3K/mTOR dual inhibitors. Pharmacokinetic analysis showed that the blood concentrations of compounds <b>46</b> and <b>48</b> at 8 h after a single 25 mpk iv dose (vehicle: 5% dextrose/lactic acid, pH 3.5) were 1731 and 1683 ng/mL, respectively.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo biomarker studies 8 h after compounds were administered at 25 mpk (iv) to MDA361 tumor bearing nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo efficacy study of compound <b>46</b> was conducted in nude mice bearing MDA361 human breast tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>46</b> was dosed at 50, 25, and 10 mg/kg, iv, once daily for 5 days weekly (two rounds). Significant tumor regression was observed in higher dose of <b>46</b> for 50 mpk and no tumor regrowth until day 32. Tumor growth inhibition was also seen in the lower doses at 25 and 10 mpk.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor efficacy of <b>46</b> in the MDA361 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of 4-morpholinopyrrolopyrimidine derivatives have been designed, synthesized, and evaluated as PI3K inhibitors. Compound <b>9</b> was found to be a selective and potent PI3Kα inhibitor with an IC<sub>50</sub> of 21 nM and selectivity over mTOR. Replacement of the 3-hydroxymethyl group with a 4-arylurea not only improved enzyme potency against PI3Kα and mTOR but also significantly increased cell potency against PC3 (prostate) and MDA361 (breast) cancer cell lines. By use of molecular modeling, 4-ureidobenzamide derivatives were designed and introduced, most of which exhibited excellent cell potency with single digit nanomolar IC<sub>50</sub> value in the tumor cell (MDA361) growth inhibition assays. Among them, compounds <b>46</b> and <b>48</b> were found to have good blood levels at 8 h after iv administration. In vivo biomarker studies showed that both compounds <b>46</b> and <b>48</b> suppressed the formation of pAkt (T308), pAkt (S473), and pS6K up to 8 h when administered at 25 mpk, iv, in the MDA361 xenograft model. On the basis of the above results, compound <b>46</b> was selected for in vivo efficacy studies in which it demonstrated in vivo antitumor efficacy in the MDA361 xenograft model. Evaluating the antitumor efficacy of <b>46</b> in other tumor models is in progress.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> General</h3><div class="NLM_p last">All solvents and reagents were used as received. <sup>1</sup>H NMR spectra were recorded with a Bruker DRX400 spectrometer; Chemical shifts are reported in parts per million (δ) using tetramethylsilane as the internal standard with coupling constants (<i>J</i>) reported in hertz (Hz). The peak shapes are denoted as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Mass spectra (MS) and high-resolution mass spectra (HRMS) were measured with an Agilent TOF 2 spectrometer. The purity of final compounds was determined by analytical HPLC using a Prodigy ODS3 column (150 mm × 4.6 mm). Conditions were as follows: ACN/H<sub>2</sub>O eluent at 1 mL/min flow (containing 0.05% TFA) at 40 °C, 20 min, gradient 5% ACN to 95% ACN, monitored by UV absorption at 215 nm. All final compounds were found to have ≥95% purity unless otherwise specified. Reversed-phase HPLC (preparative HPLC) purifications were performed on a Gilson preparative HPLC system controlled by Unipoint software using a Phenomenex Gemini column (100 mm × 30 mm). Thin-layer chromatography (TLC) was performed on TLC silica gel 60F<sub>254</sub> aluminum sheets. The terms “concentrated” and “evaporated” refer to removal of solvents using a rotary evaporator at water aspirator pressure with a bath temperature equal to or less than 40 °C.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> 4-(2-Chloro-6-methyl-5-nitropyrimidin-4-yl)morpholine (<b>3</b>)</h3><div class="NLM_p last">To a stirred solution of 2,4-dichloro-6-methyl-5-nitropyrimidine (5.0 g, 24.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added a solution of morpholine (2.1 mL, 24.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL), followed by the addition of triethylamine (6.7 mL, 48.3 mmol) at 0 °C. The resulting mixture was stirred at room temperature overnight and diluted with CH<sub>2</sub>Cl<sub>2</sub>. The organic solution was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by flash chromatography to give the title compound as a yellow solid (6.17 g, 99% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 2.46 (s, 3H), 3.57 (t, 4H, <i>J</i> = 4.58 Hz), 3.76 (t, 4H, <i>J</i> = 4.8 Hz). MS (ESI): <i>m</i>/<i>z</i> 259 [M + H].</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 3-(4-Morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenol (<b>6</b>)</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Step 1</h4><div class="NLM_p last">To a stirred solution of 4-(2-chloro-6-methyl-5-nitropyrimidin-4-yl)morpholine (<b>3</b>) (400 mg, 1.55 mmol) in 8 mL of 1,2-dimethoxymethane (DME) were added 3-benzyloxyphenylboronic acid (533 mg, 2.34 mmol), Pd(Ph<sub>3</sub>)<sub>4</sub> (90 mg, 5 mol %), and 2 N Na<sub>2</sub>CO<sub>3</sub> aqueous solution (6 mL). The resulting mixture was heated at 110 °C for 30 min in a microwave oven. The reaction mixture was cooled to room temperature, and the resultant solid was filtered off and washed with THF. The resulting filtrate was diluted with EtOAc, washed with brine, and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by flash chromatography to give 4-{2-[3-(benzyloxy)phenyl]-6-methyl-5-nitropyrimidin-4-yl}morpholine as a yellow solid (600 mg, 95% yield). MS (ESI): <i>m</i>/<i>z</i> 407 [M + H].</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Step 2</h4><div class="NLM_p last">A mixture of 4-{2-[3-(benzyloxy)phenyl]-6-methyl-5-nitropyrimidin-4-yl}morpholine (600 mg, 1.48 mmol) and 20 mL of <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (DMF−DMA) was heated at 110 °C overnight. The reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was diluted with EtOAc and filtered through a short silica gel column. The filtrate was concentrated, and the residue was triturated with diethyl ether. The resulting red solid was collected by filtration to give (<i>E</i>)-2-{2-[3-(benzyloxy)phenyl]-6-morpholin-4-yl-5-nitropyrimidin-4-yl}-<i>N</i>,<i>N</i>-dimethylethenamine (641 mg, 94% yield). MS (ESI): <i>m</i>/<i>z</i> 462 [M + H].</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Step 3</h4><div class="NLM_p last">To a solution of (<i>E</i>)-2-{2-[3-(benzyloxy)phenyl]-6-morpholin-4-yl-5-nitropyrimidin-4-yl}-<i>N</i>,<i>N</i>-dimethylethenamine (350 mg, 0.76 mmol) in 50 mL of methanol was added 40 mg of 10% Pd/C as catalyst. The resulting mixture was shaken under hydrogen (H<sub>2</sub>, 50 psi) at room temperature for 2 h. The reaction mixture was filtered through a pad of Celite. The filtration was concentrated in vacuo, and the residue was purified by flash chromatography (EtOAc/hexanes = 80:20) to give 2-[3-(benzyloxy)phenyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine as an off-white solid (249 mg, 85% yield). MS (ESI): <i>m</i>/<i>z</i> 387.2 [M + H].</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Step 4</h4><div class="NLM_p last">To a solution of 2-[3-(benzyloxy)phenyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (249 mg, 0.64 mmol) in 20 mL of methanol were added 10% Pd/C (40 mg) and acetic acid (1 mL). The resulting mixture was shaken under hydrogen (H<sub>2</sub>, 50 psi) at room temperature overnight. The reaction mixture was filtered through a pad of Celite, and the filtrate was concentrated. The residue was purified by flash column chromatography (EtOAc/hexanes = 80:20) to give <b>6</b> as an off-white solid (180 mg, 95% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.82−3.77 (m, 8H), 6.52 (d, 1H, <i>J</i> = 3.0 Hz), 6.77 (dd, 1H, <i>J</i> = 8.1, 2.8 Hz), 7.21 (t, 1H, <i>J</i> = 7.8 Hz), 7.58 (t, 1H, <i>J</i> = 3.3 Hz), 7.84−7.80 (m, 2H), 9.36 (s, 1H), 11.44 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 297 [M + H]. HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H] 297.1346, obsd 297.1348. HPLC purity 98.9%.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> [3-(4-Morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>4</b>)</h3><div class="NLM_p last">Compound <b>4</b> was prepared from <b>3</b> to give an off-white solid (41% yield), according to the procedure described for <b>6</b> (steps 1−3), using 3-(hydroxymethyl)phenylboronic acid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.80 (s, 8H), 4.57 (d, 2H, <i>J</i> = 5.5 Hz), 5.23 (d, 1H, <i>J</i> = 5.8 Hz), 6.54 (dd, 1H, <i>J</i> = 3.3, 1.5 Hz), 7.33 (d, 1H, <i>J</i> = 7.6 Hz), 7.38 (t, 1H, <i>J</i> = 7.6 Hz), 7.59 (t, 1H, <i>J</i> = 3.3 Hz), 8.25 (d, 1H, <i>J</i> = 7.6 Hz), 8.36 (s, 1H), 11.45 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 311 [M + H]. HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H] 311.1502, obsd 311.1499. HPLC purity 97.6%.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-(3-Methylphenyl)-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was isolated as an off-white solid (1.4% yield), as a byproduct in the preparation of <b>4</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.39 (s, 3H), 3.80 (s, 8H), 6.53 (dd, 1H, <i>J</i> = 3.3, 1.8 Hz), 7.20 (d, 1H, <i>J</i> = 7.8 Hz), 7.32 (t, 1H, <i>J</i> = 7.8 Hz), 7.59 (t, 1H, <i>J</i> = 2.8 Hz), 8.17 (d, 1H, <i>J</i> = 7.8 Hz), 8.20 (s, 1H), 11.46 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 295 [M + H]. HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O [M + H] 295.1553, obsd 295.1552. HPLC purity 95%.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-(4-Morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)aniline (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was prepared from <b>3</b> to give a yellow solid (53% yield), according to the procedure described for <b>6</b> using 3-nitrophenylboronic acid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.85 (t, 4H, <i>J</i> = 4.8 Hz), 4.12 (t, 4H, <i>J</i> = 4.8 Hz), 6.63 (d, 1H, <i>J</i> = 2.5 Hz), 6.91 (d, 1H, <i>J</i> = 7.8 Hz), 7.31 (t, 1H, <i>J</i> = 7.8 Hz), 7.42 (d, 1H, <i>J</i> = 7.8 Hz), 7.49 (s, 1H), 7.89 (t, 1H, <i>J</i> = 2.5 Hz), 12.50 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 296 [M + H]. HRMS calcd for C<sub>16</sub>H<sub>17</sub>N<sub>5</sub>O [M + H] 296.1506, obsd 296.1506. HPLC purity 95%.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> {3-[4-Morpholin-4-yl-7-(pyrrolidin-1-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl]phenyl}methanol (<b>9</b>)</h3><div class="NLM_p last">To a stirred solution of [3-(4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>4</b>) (19 mg, 0.06 mmol) in acetic acid (80% in water, 1 mL) was added formaldehyde (37% in water, 19 mg, 0.24 mmol), followed by addition of pyrrolidine (13 mg, 0.18 mmol). The resulting mixture was heated at 60 °C for 6 h and cooled to room temperature. The reaction mixture was concentrated, and the residue was subjected to HPLC separation to give the title compound <b>9</b> as an off-white solid (12 mg, 52% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.67 (m, 4H), 2.54 (m, 4H), 3.80 (m, 8H), 3.82 (s, 2H), 4.58 (br, 2H), 5.23 (br, 1H), 7.33 (d, 1H, <i>J</i> = 7.6 Hz), 7.39 (t, 1H, <i>J</i> = 7.6 Hz), 7.47 (s, 1H), 8.28 (d, 1H, <i>J</i> = 7.6 Hz), 8.36 (s, 1H), 11.33 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 394 [M + H]. HRMS calcd for C<sub>22</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 394.2238, obsd 394.2237. HPLC purity 95%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-{7-[(Dimethylamino)methyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl}phenyl)methanol (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared from <b>4</b> to give an off-white solid (64% yield), according to the procedure described for <b>9</b>, using dimethylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.19 (s, 6H), 3.66 (s, 2H), 3.81 (m, 8H), 4.58 (br, 2H), 5.23 (br, 1H), 7.33 (d, 1H, <i>J</i> = 7.6 Hz), 7.39 (t, 1H, <i>J</i> = 7.6 Hz), 7.47 (s, 1H), 8.29 (d, 1H, <i>J</i> = 7.6 Hz), 8.37 (s, 1H), 11.37 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 368 [M + H]. HRMS calcd for C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 368.2081, obsd 368.2078. HPLC purity 95%.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> [3-(5-Methyl-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>10</b>)</h3><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Step 1</h4><div class="NLM_p last">To a solution of [3-(4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>4</b>) (1.469 g, 4.74 mmol) in DMF (5 mL) were added imidazole (0.483 g, 7.10 mmol) and <i>tert</i>-butyldimethylsilyl chloride (0.857 g, 5.69 mmol). The resulting mixture was heated at 80 °C for 15 min in microwave oven and cooled to room temperature. The mixture was poured onto 20 mL of water and extracted with EtOAc. The combined organic phases were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by flash chromatography (EtOAc/hexanes = 1:1) to give 2-[3-({[<i>tert</i>-butyl(dimethyl)silyl]oxy}methyl)phenyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine as a white solid (1.949 g, 97% yield). MS (ESI): <i>m</i>/<i>z</i> 425 [M + H].</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Step 2</h4><div class="NLM_p last">To a solution of 2-[3-({[<i>tert</i>-butyl(dimethyl)silyl]oxy}methyl)phenyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (424 mg, 1.0 mmol) in THF (5 mL) was added NaH (60% in mineral oil, 80 mg, 2.0 mmol) at room temperature. After the mixture was stirred for 10 min, iodomethane (170 mg, 1.2 mmol) was added to the reaction mixture, and the resulting mixture was stirred at room temperature for 2 h. The reaction was quenched by addition of 2 mL of saturated aqueous ammonium chloride solution, followed by addition of 10 mL of water. The mixture was extracted with EtOAc, and combined organic phases were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was dissolved in 10 mL of CH<sub>2</sub>Cl<sub>2</sub>. To this solution was added dropwise trifluoroacetic acid (TFA, 2 mL) at room temperature. The resulting mixture was stirred at room temperature for 3 h and concentrated. The residue was treated with 1 N NaOH aqueous solution (10 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by flash chromatography to give <b>10</b> as an off-white solid (252 mg, 78% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.40 (t, 4H, <i>J</i> = 4.8 Hz), 3.85 (t, 4H, <i>J</i> = 4.8 Hz), 3.99 (s, 3H), 4.58 (d, 2H, <i>J</i> = 5.8 Hz), 5.26 (t, 1H, <i>J</i> = 5.5 Hz), 6.60 (d, 1H, <i>J</i> = 2.8 Hz), 7.35 (d, 1H, <i>J</i> = 7.6 Hz), 7.41 (t, 1H, <i>J</i> = 7.8 Hz), 7.67 (d, 1H, <i>J</i> = 3.0 Hz), 8.27 (d, 1H, <i>J</i> = 7.8 Hz), 8.38 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 325 [M + H]. HRMS calcd for C<sub>18</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub> [M + H] 325.1659, obsd 325.1663. HPLC purity 98.4%.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> {3-[5-Methyl-4-morpholin-4-yl-7-(pyrrolidin-1-ylmethyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl]phenyl}methanol (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was prepared from <b>10</b> to give an off-white solid (26% yield), according to the procedure described for <b>9</b>, using pyrrolidine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.68 (m, 4H), 2.54 (m, 4H), 3.40 (t, 4H, <i>J</i> = 4.5 Hz), 3.80 (s, 2H), 3.85 (t, 4H, <i>J</i> = 4.5 Hz), 3.92 (s, 3H), 4.59 (d, 2H, <i>J</i> = 5.3 Hz), 5.23 (t, 1H, <i>J</i> = 5.3 Hz), 7.35 (d, 1H, <i>J</i> = 7.6 Hz), 7.4 (t, 1H, <i>J</i> = 7.6 Hz), 7.55 (s, 1H), 8.3 (d, 1H, <i>J</i> = 7.6 Hz), 8.4 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 408 [M + H]. HRMS calcd for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 408.2394, obsd 408.2390. HPLC purity 97.0%.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-(4-Morpholin-4-yl-7-piperidin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenol (<b>12</b>)</h3><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Step 1</h4><div class="NLM_p last">To a solution of 2-[3-(benzyloxy)phenyl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (see preparation of <b>6</b>) (500 mg, 1.29 mmol) in methanol (5 mL) was added KOH (362 mg, 6.45 mmol, 5 equiv) and 4-piperidine monohydrate hydrochloride (495 mg, 3.23 mmol, 2.5 equiv). The resulting solution was heated at 66 °C overnight. The mixture was cooled to room temperature and concentrated. The residue was subjected to HPLC separation to give 2-[3-(benzyloxy)phenyl]-4-morpholin-4-yl-7-(1,2,3,6-tetrahydropyridin-4-yl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine as a yellow solid (300 mg, 50% yield). MS (ESI): <i>m</i>/<i>z</i> 468 [M + H].</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Step 2</h4><div class="NLM_p last">To a solution of 2-[3-(benzyloxy)phenyl]-4-morpholin-4-yl-7-(1,2,3,6-tetrahydropyridin-4-yl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidine (250 mg, 0.53 mmol) in methanol (20 mL) was added 10% Pd/C (50 mg) and concentrated HCl (30%, 0.2 mL). The resulting mixture was shaken under hydrogen (H<sub>2</sub>, 50 psi) at room temperature overnight. The reaction mixture was filtered through a pad of Celite. The filtration was concentrated, and the residue was purified by HPLC to give <b>12</b> as an off-white solid (200 mg, 99% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.79 (qd, 2H, <i>J</i> = 13.6, 3.5 Hz), 2.14 (d, 2H, <i>J</i> = 13.3 Hz), 3.01 (q, 2H, <i>J</i> = 12.1 Hz), 3.33 (t, 1H, <i>J</i> = 11.8 Hz), 3.45 (d, 2H, <i>J</i> = 12.1 Hz), 3.84 (t, 4H, <i>J</i> = 4.8 Hz), 4.13 (t, 4H, <i>J</i> = 4.8 Hz), 7.11 (dd, 1H, <i>J</i> = 8.1, 2.0 Hz), 7.45 (t, 1H, <i>J</i> = 7.8 Hz), 7.51 (t, 1H, <i>J</i> = 2.0 Hz), 7.54 (d, 1H, <i>J</i> = 7.8 Hz), 7.78 (d, 1H, <i>J</i> = 3.0 Hz), 8.48 (d, 1H, <i>J</i> = 10.3 Hz), 8.64 (d, 1H, <i>J</i> = 10.6 Hz), 12.46 (d, 1H, <i>J</i> = 3.0 Hz). MS (ESI): <i>m</i>/<i>z</i> 380 [M + H]. HRMS calcd for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 380.2081, obsd 380.2088. HPLC purity 95%.</div></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-{7-[1-(4-Fluorobenzyl)piperidin-4-yl]-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl}phenol (<b>14</b>)</h3><div class="NLM_p last">To a solution of 3-(4-morpholin-4-yl-7-piperidin-4-yl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-yl)phenol (<b>12</b>) (22 mg, 0.058 mmol) in methanol (1 mL) was added 4-fluorobenzaldehyde (22 mg, 0.177 mmol), followed by addition of ZnCl<sub>2</sub> (24 mg, 0.174 mmol) and NaCNBH<sub>3</sub> (11 mg, 0.174 mmol). The resulting mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>14</b> as an off-white solid (TFA salt, 17.2 mg, 49% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.93 (q, 2H, <i>J</i> = 12.6 Hz), 2.27 (d, 2H, <i>J</i> = 12.6 Hz), 3.07 (br, 2H), 3.22 (t, 1H, <i>J</i> = 11.6 Hz), 3.52 (d, 2H, <i>J</i> = 11.6 Hz), 3.81 (t, 4H, <i>J</i> = 4.5 Hz), 3.95 (br, 4H), 4.40 (s, 2H), 6.95 (s, 1H), 7.31 (t, 1H, <i>J</i> = 7.4 Hz), 7.35 (t, 2H, <i>J</i> = 8.6 Hz), 7.54 (br, 1H), 7.63 (dd, 2H, <i>J</i> = 8.6, 5.4 Hz), 7.68 (br, 2H), 9.98 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 488 [M + H]. HRMS calcd for C<sub>28</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>2</sub> [M + H] 488.2456, obsd 488.2455. HPLC purity 96.1%.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-[7-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-5<i>H</i>-pyrrolo[3,2-d]pyrimidin-2-yl]phenol (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared from <b>12</b> to give an off-white solid (TFA salt, 57% yield), according to the procedure described for <b>14</b>, using benzaldehyde. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.93 (q, 2H, <i>J</i> = 12.5 Hz), 2.27 (d, 2H, <i>J</i> = 12.5 Hz), 3.09 (br, 2H), 3.12 (t, 1H, <i>J</i> = 11.7 Hz), 3.52 (d, 2H, <i>J</i> = 11.7 Hz), 3.81 (t, 4H, <i>J</i> = 4.5 Hz), 3.95 (br, 4H), 4.40 (s, 2H), 6.95 (br, 1H), 7.33 (t, 1H, <i>J</i> = 7.4 Hz), 7.60−7.47 (m, 6H), 7.65 (br, 2H), 9.97 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 470 [M + H]. HRMS calcd for C<sub>28</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 470.2551, obsd 470.2548. HPLC purity 97.7%.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> [3-(4-Morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>17</b>)</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 1. 7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diol (<b>15</b>)</h4><div class="NLM_p last">To a suspended solution of 6-aminouracil (12.7 g, 100 mmol) and sodium acetate (8.2 g, 100 mmol) in H<sub>2</sub>O (100 mL) at a temperature of 70−75 °C was added a solution of chloroacetaldehyde (50% in water, 23.6 g, 150 mmol). The resulting reaction mixture was stirred at 80 °C for 20 min and then cooled to room temperature. The resulting solid was collected by filtration, washed with water and acetone, and dried in vacuo to give <b>15</b> as brown solid (14.74 g, 98% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 6.22 (s, 1H), 6.56 (s, 1H), 10.46 (s, 1H), 11.08 (br, 1H), 11.43 (br, 1H). MS (ESI, negative): <i>m</i>/<i>z</i> 150 [M − H].</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 2. 2,4-Dichloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (15a)</h4><div class="NLM_p last">To a 20 mL vial were added 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diol (<b>15</b>) (2.5 g, 16.6 mmol), POCl<sub>3</sub> (10 mL, 107 mmol), and <i>N</i>,<i>N</i>-dimethylaniline (1 mL, 7.9 mmol). The resulting mixture was heated at 120 °C for 30 min in a microwave oven. The reaction mixture was cooled to room temperature and poured onto ice (about 200 g). The resulting solid was filtered and washed with water to give dichloro <b>15a</b> as a brown solid (1.323 g, 43% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 6.67 (m, 1H), 7.74 (m, 1H), 12.78 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 188 [M + H].</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Step 3. 2-Chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine <b>(16)</b></h4><div class="NLM_p last">To a solution of 2,4-dichloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (1.38 g, 7.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) were added morpholine (0.96 mL, 11 mmol) and Et<sub>3</sub>N (2.1 mL, 15 mmol). The mixture was stirred at room temperature overnight. The resulting solid was filtered and washed with EtOH and water to give <b>16</b> as a yellow solid (1.19 g, 68%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.72 (t, 4H, <i>J</i> = 5.0 Hz), 3.84 (t, 4H, <i>J</i> = 5.0 Hz), 6.67 (dd, 1H, <i>J</i> = 3.3, 1.3 Hz), 7.21(dd, 1H, <i>J</i> = 3.8, 2.3 Hz), 11.91 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 239 [M + H].</div></div><div id="sec5_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 4. [3-(4-Morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]methanol (<b>17</b>)</h4><div class="NLM_p last">To a 10 mL vial were added 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (150 mg, 0.63 mmol), 3-hydroxymethylphenylboronic acid (144 mg, 0.94 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (36 mg, 5 mol %), 1,2-dimethoxyethane (DME, 2.5 mL), and 2 M Na<sub>2</sub>CO<sub>3</sub> aqueous solution (1.5 mL). The resulting mixture was heated at 120 °C for 1 h in a microwave oven. The reaction mixture was cooled to room temperature and diluted with EtOAc. The aqueous phase was extracted with EtOAc, and the combined organic phases were washed with brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>17</b> as an off-white solid (98 mg, 50% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.78 (t, 4H, <i>J</i> = 4.8 Hz), 3.95 (t, 4H, <i>J</i> = 4.8 Hz), 4.58 (d, 2H, <i>J</i> = 5.8 Hz), 5.24 (t, 1H, <i>J</i> = 5.8 Hz), 6.66 (d, 1H, <i>J</i> = 3.5 Hz), 7.24 (dd, 1H, <i>J</i> = 3.5, 2.8 Hz), 7.35 (d, 1H, <i>J</i> = 7.3 Hz), 7.40 (t, 1H, <i>J</i> = 7.8 Hz), 8.24 (d, 1H, <i>J</i> = 7.8 Hz), 8.35 (s, 1H), 11.80 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 311 [M + H]. HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H] 311.1502, obsd 311.1501. HPLC purity 95%.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(4-Morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenol (<b>18</b>)</h3><div class="NLM_p last">Following the same procedure as for the preparation of <b>17</b>, Suzuki coupling of 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (150 mg, 0.63 mmol) with 3-hydroxyphenylboronic acid (130 mg, 0.94 mmol) gave <b>18</b> as a yellow solid (130 mg, 70% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.78 (t, 4H, <i>J</i> = 5.0 Hz), 3.93 (t, 4H, <i>J</i> = 5.0 Hz), 6.65 (d, 1H, <i>J</i> = 3.3 Hz), 6.80 (dd, 1H, <i>J</i> = 8.3, 2.5 Hz), 7.23 (dd, 2H, <i>J</i> = 7.8, 4.5 Hz), 7.80 (m, 2H), 9.40 (s, 1H), 11.77 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 297 [M + H]. HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H] 297.1346, obsd 297.1347. HPLC purity 95.3%.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Chloro-4-morpholin-4-yl-7-[2-(dimethylamino)ethyl]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>19</b>)</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (154 mg, 0.65 mmol) in DMF (5 mL) were added 2-(dimethylamino)ethyl chloride hydrochloride (140 mg, 0.97 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (635 mg, 1.95 mmol). The resulting mixture was heated at 80 °C under nitrogen overnight and cooled to room temperature. Water was added, and the mixture was extracted with EtOAc. The combined extracts were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated to give <b>19</b> as a yellow syrup (169 mg, 84% yield), which was used in next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 2.27 (s, 6H), 2.68 (t, 2H, <i>J</i> = 6.4 Hz), 3.82 (t, 4H, <i>J</i> = 4.9 Hz), 3.94 (t, 4H, <i>J</i> = 5.3 Hz), 4.25 (t, 2H, <i>J</i> = 6.4 Hz), 6.43 (d, 1H, <i>J</i> = 3.8 Hz), 7.03 (d, 1H, <i>J</i> = 3.8 Hz). MS (ESI): <i>m</i>/<i>z</i> 310 [M + H].</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (3-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)methanol (<b>20</b>)</h3><div class="NLM_p last">Following the same procedure as for the preparation of <b>17</b>, Suzuki coupling of 2-chloro-4-morpholin-4-yl-7-[2-(dimethylamino)ethyl]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>19</b>) (80 mg, 0.26 mmol) and 3-hydroxymethylphenylboronic acid (58 mg, 0.38 mmol) gave <b>20</b> as an off-white solid (96 mg, 88% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) δ 3.01 (s, 6H), 3.79−3.71 (m, 2H), 3.94 (t, 4H, <i>J</i> = 4.9 Hz), 4.11 (t, 4H, <i>J</i> = 5.3 Hz), 4.76 (s, 2H), 4.87 (m, 2H), 7.09 (d, 1H, <i>J</i> = 3.8 Hz), 7.66−7.56 (m, 3H), 8.07 (d, 1H, <i>J</i> = 7.5 Hz), 8.17 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 382 [M + H]. HRMS calcd for C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 382.22386, obsd 382.2235. HPLC purity 97.5%.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenol (<b>21</b>)</h3><div class="NLM_p last">Following the same procedure as for the preparation of <b>17</b>, Suzuki coupling of 2-chloro-4-morpholin-4-yl-7-[2-(dimethylamino)ethyl]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>19</b>) (80 mg, 0.26 mmol) and 3-hydroxyphenylboronic acid (54 mg, 0.38 mmol) gave <b>21</b> as an off-white solid (81.9 mg, 78% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) δ 3.01 (s, 6H), 3.74 (t, 2H, <i>J</i> = 6.0 Hz), 3.90 (t, 4H, <i>J</i> = 5.3 Hz), 4.06 (t, 4H, <i>J</i> = 5.3 Hz), 4.79 (t, 2H, <i>J</i> = 6.0 Hz), 6.96 (d, 1H, <i>J</i> = 3.8 Hz), 7.0 (dd, 1H, <i>J</i> = 7.9, 2.3 Hz), 7.37 (t, 1H, <i>J</i> = 7.9 Hz), 7.50 (d, 1H, <i>J</i> = 3.8 Hz), 7.68−7.62 (m, 2H). MS (ESI): <i>m</i>/<i>z</i> 368 [M + H]. HRMS calcd for C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub> [M + H] 368.2081, obsd 368.2082. HPLC purity 98.8%.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}aniline (<b>22</b>)</h3><div class="NLM_p last">Following the same procedure as for the preparation of <b>17</b>, Suzuki coupling of 2-chloro-4-morpholin-4-yl-7-[2-(dimethylamino)ethyl]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>19</b>) (261 mg, 0.84 mmol) and 4-aminophenylboronic acid pinacol ester (277 mg, 1.27 mmol) gave <b>22</b> as a yellow oil (278 mg, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 2.32 (s, 6H), 2.76 (t, 2H, <i>J</i> = 6.4 Hz), 3.86 (t, 4H, <i>J</i> = 5.3 Hz), 4.0 (t, 4H, <i>J</i> = 5.3 Hz), 4.37 (t, 2H, <i>J</i> = 6.4 Hz), 6.42 (d, 1H, <i>J</i> = 3.8 Hz), 6.72 (d, 2H, <i>J</i> = 8.7 Hz), 6.98 (d, 1H, <i>J</i> = 3.8 Hz), 8.30 (d, 2H, <i>J</i> = 8.7 Hz). MS (ESI): <i>m</i>/<i>z</i> 367 [M + H].</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-pyridin-2-ylurea (<b>23</b>)</h3><div class="NLM_p last">To a solution of 4-{7-[2-(dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}aniline (<b>22</b>) (22 mg, 0.06 mmol) in CHCl<sub>3</sub> (1 mL) were added Et<sub>3</sub>N (25 μL, 0.18 mmol) and triphosgene (18 mg, 0.06 mmol). The mixture was stirred at room temperature for 15 min, and 2-aminopyridine (17 mg, 0.18 mmol) was added. The mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>23</b> as an off-white solid (15 mg, 51% yield). MS (ESI): <i>m</i>/<i>z</i> 487 [M + H]. HRMS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>8</sub>O<sub>2</sub> [M + H] 487.2564, obsd 487.2561. HPLC purity 99.0%.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-pyridin-3-ylurea (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared from <b>22</b> to give an off-white solid (45% yield), according to the procedure described for <b>23</b>, using 3-aminopyridine. MS (ESI): <i>m</i>/<i>z</i> 487 [M + H]. HRMS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>8</sub>O<sub>2</sub> [M + H] 487.2564, obsd 487.2564. HPLC purity 96.0%.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-pyridin-4-ylurea (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was prepared from <b>22</b> to give an off-white solid (62% yield), according to the procedure described for <b>23</b>, using 4-aminopyridine. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 2.34 (s, 6H), 2.83 (t, 2H, <i>J</i> = 6.8 Hz), 3.85 (t, 4H, <i>J</i> = 5.0 Hz), 4.00 (t, 4H, <i>J</i> = 5.3 Hz), 4.42 (t, 2H, <i>J</i> = 7.1 Hz), 6.60 (d, 1H, <i>J</i> = 3.5 Hz), 7.16 (d, 1H, <i>J</i> = 3.5 Hz), 7.52 (t, 2H, <i>J</i> = 1.8 Hz), 7.54 (d, 2H, <i>J</i> = 1.8 Hz), 8.32 (dd, 2H, <i>J</i> = 4.8, 1.5 Hz), 8.39 (d, 2H, <i>J</i> = 8.3 Hz). MS (ESI): <i>m</i>/<i>z</i> 487 [M + H]. HRMS calcd for C<sub>26</sub>H<sub>3</sub>0N<sub>8</sub>O<sub>2</sub> [M + H] 487.2564, obsd 487.2564. HPLC purity 95%.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-(4-fluorophenyl)urea (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared from <b>22</b> to give an off-white solid (33% yield), according to the procedure described for <b>23</b>, using 4-fluoroaniline. MS (ESI): <i>m</i>/<i>z</i> 504 [M + H]. HRMS calcd for C<sub>27</sub>H<sub>30</sub>FN<sub>7</sub>O<sub>2</sub> [M + H] 504.2518, obsd 504.2515. HPLC purity 95%.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-ethylurea (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared from <b>22</b> to give a yellow solid (41% yield), according to the procedure described for <b>23</b>, using ethylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.06 (t, 3H, <i>J</i> = 7.1 Hz), 2.88 (s, 6H), 3.12 (q, 2H, <i>J</i> = 7.1 Hz), 3.61 (br, 2H), 3.77 (t, 4H, <i>J</i> = 4.5 Hz), 3.94 (t, 4H, <i>J</i> = 4.5 Hz), 4.62 (t, 2H, <i>J</i> = 6.1 Hz), 6.27 (br, 1H), 6.75 (d, 1H, <i>J</i> = 3.6 Hz), 7.33 (d, 1H, <i>J</i> = 3.6 Hz), 7.49 (d, 2H, <i>J</i> = 8.7 Hz), 8.28 (d, 2H, <i>J</i> = 8.7 Hz), 8.71 (s, 1H), 9.65 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 438 [M + H]. HRMS calcd for C<sub>23</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub> [M + H] 438.2612, obsd 438.2609. HPLC purity 97.2%.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-methylurea (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared from <b>22</b> to give a yellow solid (34% yield), according to the procedure described for <b>23</b>, using methylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.66 (s, 3H), 2.88 (s, 6H), 3.61 (br, 2H), 3.77 (t, 4H, <i>J</i> = 4.5 Hz), 3.94 (t, 4H, <i>J</i> = 4.5 Hz), 4.61 (t, 2H, <i>J</i> = 6.1 Hz), 6.12 (br, 1H), 6.75 (d, 1H, <i>J</i> = 3.6 Hz), 7.33 (d, 1H, <i>J</i> = 3.6 Hz), 7.50 (d, 2H, <i>J</i> = 8.7 Hz), 8.28 (d, 2H, <i>J</i> = 8.7 Hz), 8.78 (s, 1H), 9.60 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 424 [M + H]. HRMS calcd for C<sub>22</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub> [M + H] 424.2456, obsd 424.2453. HPLC purity 98.2%.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-[4-(4-Morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]-3-pyridin-4-ylurea (<b>29</b>)</h3><div class="NLM_p last">To a 10 mL vial were charged 4-isocyantophenylboronic acid, pinacol ester (368 mg, 1.5 mmol), 4-aminopyridine (188 mg, 2.0 mmol), Et<sub>3</sub>N (0.28 mL, 2.0 mmol), and DME (3 mL). The mixture was stirred at room temperature for 5 h, and to the mixture were then added 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (238 mg, 1.0 mmol), Na<sub>2</sub>CO<sub>3</sub> aqueous solution (2 M, 2 mL), and Pd(PPh<sub>3</sub>)<sub>4</sub> (58 mg, 5 mol %). The resulting mixture was heated at 120 °C for 30 min in microwave oven. The reaction mixture was cooled to room temperature and diluted with EtOAc. The aqueous phase was extracted with EtOAc, and the combined organic phases were washed with brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>29</b> as a yellow solid (66 mg, 16% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.78 (t, 4H, <i>J</i> = 4.5 Hz), 3.95 (t, 4H, <i>J</i> = 5.0 Hz), 6.66 (m, 1H), 7.23 (m, 1H), 7.63 (d, 2H, <i>J</i> = 8.6 Hz), 7.96 (d, 2H, <i>J</i> = 7.3 Hz), 8.34 (d, 2H, <i>J</i> = 8.6 Hz), 8.62 (d, 2H, <i>J</i> = 7.6 Hz), 9.96 (s, 1H), 10.84 (s, 1H), 11.79 (s, 1H). MS(ESI): <i>m</i>/<i>z</i> 416 [M + H]. HRMS calcd for C<sub>22</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub> [M + H] 416.1829, obsd 416.1830. HPLC purity 95%.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Chloro-4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>30</b>)</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (340 mg, 1.4 mmol) in DMF (5 mL) were added 1,1,1-trifluoro-2-iodoethane (0.28 mL, 2.8 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (559 mg, 1.7 mmol). The resulting mixture was heated at 80 °C under nitrogen overnight and cooled to room temperature. The reaction mixture was quenched with water and extracted with EtOAc. The combined extracts were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated to give <b>30</b> as a light-yellow solid (199 mg, 43% yield), which was used in the next step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.72 (t, 4H, <i>J</i> = 5.0 Hz), 3.86 (t, 4H, <i>J</i> = 5.0 Hz), 5.05 (q, 2H, <i>J</i> = 9.3 Hz), 6.84 (d, 1H, <i>J</i> = 3.5 Hz), 7.34 (d, 1H, <i>J</i> = 3.8 Hz). MS (ESI): <i>m</i>/<i>z</i> 321 [M + H].</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-[7-(2,2,2-Trifluoroethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]aniline (<b>42</b>)</h3><div class="NLM_p last">To a 10 mL vial were added 2-chloro-4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>30</b>) (294 mg, 0.9 mmol), 4-aminophenylboronic acid pinacol ester (302 mg, 1.4 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (53 mg, 5 mol %), 1,2-dimethoxyethane (DME, 3 mL), and Na<sub>2</sub>CO<sub>3</sub> aqueous solution (2 M, 2 mL). The resulting mixture was heated at 130 °C for 30 min in a microwave oven. The reaction mixture was cooled to room temperature and diluted with EtOAc. The aqueous phase was extracted with EtOAc, and the combined organic phases were washed with brine and dried over MgSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by flash chromatography to give <b>42</b> as a brown oil (286 mg, 83% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.77 (t, 4H, <i>J</i> = 5.0 Hz), 3.91 (t, 4H, <i>J</i> = 4.8 Hz), 5.12 (q, 2H, <i>J</i> = 9.3 Hz), 5.44 (s, 2H), 6.61 (d, 2H, <i>J</i> = 9.3 Hz), 6.74 (d, 1H, <i>J</i> = 4.0 Hz), 7.25 (d, 1H, <i>J</i> = 4.0 Hz), 8.12 (d, 2H, <i>J</i> = 9.1 Hz). MS (ESI): <i>m</i>/<i>z</i> 378 [M + H].</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-{4-[4-Morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>32</b>)</h3><div class="NLM_p last">To a solution of 4-[7-(2,2,2-trifluoroethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]aniline (<b>42</b>) (25 mg, 0.066 mmol) in CHCl<sub>3</sub> (1 mL) were added Et<sub>3</sub>N (28 μL, 0.2 mmol) and triphosgene (20 mg, 0.066 mmol). The mixture was stirred at room temperature for 15 min before a solution of 4-aminopyridine (19 mg, 0.2 mmol) in THF (1 mL) was added. The mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>32</b> as an off-white solid (24.5 mg, 61% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 3.78 (t, 4H, <i>J</i> = 5.3 Hz), 3.97 (t, 4H, <i>J</i> = 5.3 Hz), 5.18 (q, 2H, <i>J</i> = 9.8 Hz), 6.82 (d, 1H, <i>J</i> = 3.8 Hz), 7.35 (d, 1H, <i>J</i> = 3.8 Hz), 7.63 (d, 2H, <i>J</i> = 8.7 Hz), 7.94 (d, 2H, <i>J</i> = 7.2 Hz), 8.41 (d, 2H, <i>J</i> = 8.7 Hz), 8.61 (d, 2H, <i>J</i> = 7.2 Hz), 9.85 (s, 1H), 10.64 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 498 [M + H]. HRMS calcd for C<sub>24</sub>H<sub>22</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub> [M + H] 498.1860, obsd 498.1860. HPLC purity 97.6%.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Chloro-7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>31</b>)</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>16</b>) (650 mg, 2.7 mmol) in DMF (10 mL) were added 2-bromo-1,1-dimethoxyethane (0.65 mL, 5.4 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (1.067 g, 3.3 mmol). The resulting mixture was heated at 80 °C under nitrogen overnight and cooled to room temperature. Water was added, and the mixture was extracted with EtOAc. The combined extracts were washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was evaporated to give <b>31</b> as a light-yellow solid (665 mg, 75% yield), which was used in the next step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.27 (s, 6H), 3.72 (t, 4H, <i>J</i> = 5.0 Hz), 3.84 (t, 4H, <i>J</i> = 5.3 Hz), 4.20 (d, 2H, <i>J</i> = 5.5 Hz), 4.67 (t, 1H, <i>J</i> = 5.3 Hz), 6.7 (d, 1H, <i>J</i> = 4.0 Hz), 7.26 (d, 1H, <i>J</i> = 3.8 Hz). MS (ESI): <i>m</i>/<i>z</i> 327 [M + H].</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-{4-[7-(2,2-Dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>33</b>)</h3><div id="sec5_31_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step 1</h4><div class="NLM_p last">To a 20 mL vial were added 2-chloro-7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>31</b>) (665 mg, 2 mmol), 4-aminophenylboronic acid pinacol ester (670 mg, 3 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (118 mg, 5 mol %), 1,2-dimethoxyethane (DME, 6 mL), and sodium carbonate aqueous solution (2M, 4 mL). The resulting mixture was heated at 130 °C for 30 min in a microwave oven. The reaction mixture was cooled to room temperature and diluted with EtOAc. The aqueous phase was extracted with EtOAc, and the combined organic solution was concentrated. The residue was purified by flash chromatography to give 4-[7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]aniline as a brown oil (760 mg, 97% yield). MS (ESI): <i>m</i>/<i>z</i> 384 [M + H].</div></div><div id="sec5_31_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step 2</h4><div class="NLM_p last">To a solution of 4-[7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]aniline (766 mg, 2 mmol) in CHCl<sub>3</sub> (10 mL) were added Et<sub>3</sub>N (0.55 mL, 3.9 mmol) and triphosgene (594 mg, 2 mmol). The mixture was stirred at room temperature for 15 min before a solution of 4-aminopyridine (564 mg, 6 mmol) in THF (10 mL) was added. The mixture was heated at 50 °C overnight. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>33</b> as a yellow solid (350 mg, 35% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.31 (s, 6H), 3.78 (t, 4H, <i>J</i> = 4.8 Hz), 3.95 (t, 4H, <i>J</i> = 4.8 Hz), 4.35 (d, 2H, <i>J</i> = 5.3 Hz), 4.78 (t, 1H, <i>J</i> = 5.3 Hz), 6.67 (d, 1H, <i>J</i> = 3.5 Hz), 7.27 (d, 1H, <i>J</i> = 3.5 Hz), 7.52 (d, 2H, <i>J</i> = 6.5 Hz), 7.57 (d, 2H, <i>J</i> = 8.8 Hz), 8.35 (d, 2H, <i>J</i> = 8.8 Hz), 8.40 (d, 2H, <i>J</i> = 6.5 Hz), 9.15 (s, 1H), 9.32 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 504 [M + H]. HRMS calcd for C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>4</sub> [M + H] 504.2354, obsd 504.2358. HPLC purity 95%.</div></div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-{4-[4-Morpholin-4-yl-7-(2-oxoethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>34</b>)</h3><div class="NLM_p last">A mixture of 1-{4-[7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>33</b>) (300 mg, 0.6 mmol), dioxane (3 mL), and 6 M HCl (3 mL) was heated at 70 °C for 3 h and cooled to room temperature. The mixture was concentrated in vacuo, and the residue was triturated with EtOAc. The resulting solid was collected by filtration and washed with EtOAc to give <b>34</b> as an off-white solid (479 mg, 85% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.79 (t, 4H, <i>J</i> = 4.5 Hz), 3.96 (t, 4H, <i>J</i> = 4.5 Hz), 5.21(s, 2H), 6.74 (d, 1H, <i>J</i> = 3.6 Hz), 7.25 (d, 1H, <i>J</i> = 3.6 Hz), 7.60 (d, 2H, <i>J</i> = 8.6 Hz), 7.94 (d, 2H, <i>J</i> = 6.7 Hz), 8.35 (d, 2H, <i>J</i> = 8.6 Hz), 8.61 (d, 2H, <i>J</i> = 6.7 Hz), 9.72 (s, 1H), 9.81 (s, 1H), 10.62 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 458 [M + H]. HPLC purity 95%.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-{4-[4-Morpholin-4-yl-7-(2-pyrrolidin-1-ylethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>35</b>)</h3><div class="NLM_p last">To a solution of 1-{4-[4-morpholin-4-yl-7-(2-oxoethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>34</b>) (24 mg, 0.05 mmol) in MeOH (2 mL) were added pyrrolidine (22 mg, 0.3 mmol), ZnCl<sub>2</sub> (14 mg, 0.1 mmol), and NaBH<sub>3</sub>CN (6 mg, 0.1 mmol). The resulting mixture was stirred at room temperature for 2 h, and 0.5 mL of NaOH (1 M in water) was added. The solvent was evaporated, and the residue was subjected to HPLC separation to give <b>35</b> as an off-white solid (9.2 mg, 25% yield). MS (ESI): <i>m</i>/<i>z</i> 513 [M + H]. HRMS calcd for C<sub>28</sub>H<sub>32</sub>N<sub>8</sub>O<sub>2</sub> [M + H] 513.2721, obsd 513.2718. HPLC purity 95%.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-{4-[4-Morpholin-4-yl-7-(2-piperidin-1-ylethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared from <b>34</b> to give an off-white solid (27% yield), according to the procedure described for <b>35</b>, using piperidine. MS (ESI): <i>m</i>/<i>z</i> 527 [M + H]. HRMS calcd for C<sub>29</sub>H<sub>34</sub>N<sub>8</sub>O<sub>2</sub> [M + H] 527.2880, obsd 527.2877. HPLC purity 95.7%.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-{4-[7-(2-{[2-(Dimethylamino)ethyl]amino}ethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared from <b>34</b> to give an off-white solid (37% yield), according to the procedure described for <b>35</b>, using <i>N</i>,<i>N</i>-dimethylethylenediamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.81 (s, 6H), 3.33 (m, 2H), 3.42 (m, 2H), 3.54 (t, 2H, <i>J</i> = 6.1 Hz), 3.78 (t, 4H, <i>J</i> = 4.5 Hz), 3.96 (m, 4H), 4.58 (d, 2H, <i>J</i> = 6.3 Hz), 6.77 (d, 1H, <i>J</i> = 3.6 Hz), 7.32 (d, 1H, <i>J</i> = 3.6 Hz), 7.66 (d, 2H, <i>J</i> = 8.7 Hz), 7.98 (d, 2H, <i>J</i> = 6.8 Hz), 8.42 (d, 2H, <i>J</i> = 8.7 Hz), 8.63 (d, 2H, <i>J</i> = 6.8 Hz), 10.46 (s, 1H), 11.38 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 530 [M + H]. HRMS calcd for C<sub>28</sub>H<sub>35</sub>N<sub>9</sub>O<sub>2</sub> [M + H] 530.2986, obsd 530.2976. HPLC purity 95%.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-(4-{7-[2-(4-Methylpiperazin-1-yl)ethyl]-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl}phenyl)-3-pyridin-4-ylurea (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared from <b>34</b> to give an off-white solid (42% yield), according to the procedure described for <b>35</b>, using 1-methylpiperazine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.74 (s, 3H), 2.95 (t, 2H, <i>J</i> = 6.0 Hz), 3.30 (br, 8H), 3.78 (t, 4H, <i>J</i> = 4.5 Hz), 3.95 (t, 4H, <i>J</i> = 4.5 Hz), 4.42 (t, 2H, <i>J</i> = 6.0 Hz), 6.68 (d, 1H, <i>J</i> = 3.6 Hz), 7.35 (d, 1H, <i>J</i> = 3.6 Hz), 7.66 (d, 2H, <i>J</i> = 8.7 Hz), 7.98 (d, 2H, <i>J</i> = 7.0 Hz), 8.38 (d, 2H, <i>J</i> = 8.7 Hz), 8.63 (d, 2H, <i>J</i> = 7.0 Hz), 10.46 (s, 1H), 11.41 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 542 [M + H]. HRMS calcd for C<sub>29</sub>H<sub>35</sub>N<sub>9</sub>O<sub>2</sub> [M + H] 542.2986, obsd 542.2981. HPLC purity 96.5%.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-{4-[4-Morpholin-4-yl-7-(2-piperazin-1-ylethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was prepared from <b>34</b> to give an off-white solid (39% yield), according to the procedure described for <b>35</b>, using piperazine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.90 (br, 4H), 2.99 (br, 2H), 3.07 (br, 4H), 3.78 (t, 4H, <i>J</i> = 4.5 Hz), 3.95 (t, 4H, <i>J</i> = 4.5 Hz), 4.43 (t, 2H, <i>J</i> = 6.0 Hz), 6.69 (d, 1H, <i>J</i> = 3.6 Hz), 7.35 (d, 1H, <i>J</i> = 3.6 Hz), 7.66 (d, 2H, <i>J</i> = 8.8 Hz), 7.98 (d, 2H, <i>J</i> = 7.0 Hz), 8.38 (d, 2H, <i>J</i> = 8.8 Hz), 8.62 (d, 2H, <i>J</i> = 7.0 Hz), 10.40 (s, 1H), 11.40 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 528 [M + H]. HRMS calcd for C<sub>28</sub>H<sub>33</sub>N<sub>9</sub>O<sub>2</sub> [M + H] 528.2830, obsd 528.2828. HPLC purity 95.5%.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-{4-[7-(2-Hydroxyethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>40</b>)</h3><div class="NLM_p last">To a stirred mixture of 1-{4-[4-morpholin-4-yl-7-(2-oxoethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea (<b>34</b>) (215 mg, 0.47 mmol), MeOH (4 mL), and THF (4 mL) was added NaBH<sub>4</sub> (27 mg, 0.7 mmol). The resulting mixture was stirred at room temperature for 30 min, and 2 mL of NaOH (1 M in water) was added. The mixture was concentrated, and the residue was subjected to HPLC separation to give <b>40</b> as an off-white solid (165 mg, 76% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.78 (t, 6H, <i>J</i> = 5.0 Hz), 3.94 (t, 4H, <i>J</i> = 5.0 Hz), 4.29 (t, 2H, <i>J</i> = 5.5 Hz), 4.96 (t, 1H, <i>J</i> = 5.5 Hz), 6.65 (d, 1H, <i>J</i> = 3.8 Hz), 7.29 (d, 1H, <i>J</i> = 3.8 Hz), 7.45 (d, 2H, <i>J</i> = 6.3 Hz), 7.56 (d, 2H, <i>J</i> = 8.6 Hz), 8.34 (d, 2H, <i>J</i> = 8.6 Hz), 8.37 (d, 2H, <i>J</i> = 6.3 Hz), 9.06 (s, 1H), 9.13 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 460 [M + H]. HRMS calcd for C<sub>24</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub> [M + H] 460.2092, obsd 460.2092. HPLC purity 98.1%.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-({[4-(7-(2,2,2-Trifluoroethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzoic Acid (<b>44</b>)</h3><div id="sec5_39_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Step 1</h4><div class="NLM_p last">To a solution of 4-[7-(2,2,2-trifluoroethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]aniline (<b>42</b>) (479 mg, 1.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added methyl 4-isocyanatobenzoate (269 mg, 1.5 mmol), and the resulting mixture was stirred at room temperature overnight. The resulting solid was collected by filtration and washed with CH<sub>2</sub>Cl<sub>2</sub> to give methyl 4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzoate as an off-white solid (539 mg, 77% yield). MS (ESI): <i>m</i>/<i>z</i> 555 [M + H].</div></div><div id="sec5_39_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Step 2</h4><div class="NLM_p last">To a solution of methyl 4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzoate (500 mg, 0.9 mmol) in MeOH (30 mL) and THF (10 mL) was added 1 N NaOH aqueous solution (2.7 mL), and the mixture was heated at 70 °C overnight. The mixture was cooled to room temperature and concentrated. The residue was treated water and acidified to pH 4−5 by addition of 1 N HCl, and the resulting solid was collected by filtration, washed with water, and dried in air to give <b>44</b> as an off-white solid (486 mg, 100% yield). MS (ESI): <i>m</i>/<i>z</i> 541 [M + H].</div></div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-[2-(Dimethylamino)ethyl]-<i>N</i>-methyl-4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzamide (<b>46</b>)</h3><div class="NLM_p last">To a solution of 4-({[4-(7-(2,2,2-trifluoroethyl)-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzoic acid (<b>44</b>) (32 mg, 0.06 mmol) in THF (2 mL) were added <i>N</i>,<i>N</i>,<i>N</i>′-trimethylethylenediamine (12 mg, 0.12 mmol), Et<sub>3</sub>N (12 mg, 0.12 mmol), HOBt (16 mg, 0.12 mmol), and EDCI (23 mg, 0.12 mmol). The resulting mixture was stirred at room temperature overnight and concentrated. The residue was subjected to HPLC separation to give <b>46</b> as an off-white solid (TFA salt, 38.6 mg, 87% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.83 (br, 6H), 3.02 (s, 3H), 3.35 (q, 2H, <i>J</i> = 5.8 Hz), 3.79 (br, 6H), 3.97 (br, 4H), 5.19 (q, 2H, <i>J</i> = 8.6 Hz), 6.82 (d, 1H, <i>J</i> = 3.8 Hz), 7.35 (d, 1H, <i>J</i> = 3.8 Hz), 7.47 (d, 2H, <i>J</i> = 8.3 Hz), 7.57 (t, 4H, <i>J</i> = 8.3 Hz), 8.36 (d, 2H, <i>J</i> = 8.8 Hz), 9.48 (s, 1H), 9.54 (s, 1H), 10.03 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 625 [M + H]. HRMS calcd for C<sub>31</sub>H<sub>35</sub>F<sub>3</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 625.2857, obsd 625.2857. HPLC purity 96.7%.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-[2-(Dimethylamino)ethyl]-4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzamide (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was prepared from <b>44</b> to give an off-white solid (TFA salt, 99% yield), according to the procedure described for <b>46</b>, using <i>N</i>,<i>N</i>-dimethylethylenediamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.83 (s, 3H), 2.84 (s, 3H), 3.26 (q, 2H, <i>J</i> = 5.8 Hz), 3.62 (q, 2H, <i>J</i> = 5.8 Hz), 3.78 (t, 4H, <i>J</i> = 4.8 Hz), 3.96 (t, 4H, <i>J</i> = 4.8 Hz), 5.18 (q, 2H, <i>J</i> = 8.6 Hz), 6.81 (d, 1H, <i>J</i> = 3.8 Hz), 7.34 (d, 1H, <i>J</i> = 3.8 Hz), 7.57 (dd, 4H, <i>J</i> = 8.6, 1.8 Hz), 7.87 (d, 2H, <i>J</i> = 8.6 Hz), 8.35 (d, 2H, <i>J</i> = 8.6 Hz), 8.67 (t, 1H, <i>J</i> = 5.8 Hz), 9.51 (s, 1H), 9.59 (s, 1H), 9.94 (br, 1H). MS (ESI): <i>m</i>/<i>z</i> 611 [M + H]. HRMS calcd for C<sub>30</sub>H<sub>33</sub>F<sub>3</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 611.2700, obsd 611.2700. HPLC purity 96.8%.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-{4-[(4-Methylpiperazin-1-yl)carbonyl]phenyl}-3-{4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}urea (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was prepared from <b>44</b> to give an off-white solid (TFA salt, 97% yield), according to the procedure described for <b>46</b>, using 1-methylpiperazine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 2.78 (s, 3/2 H), 2.79 (s, 3/2H), 3.07 (m, 2H), 3.40 (m, 4H), 3.78 (t, 4H, <i>J</i> = 4.8 Hz), 3.96 (t, 4H, <i>J</i> = 4.8 Hz), 5.18 (q, 2H, <i>J</i> = 8.6 Hz), 6.81 (d, 1H, <i>J</i> = 3.5 Hz), 7.34 (d, 1H, <i>J</i> = 3.5 Hz), 7.34 (d, 1H, <i>J</i> = 3.5 Hz), 7.42 (d, 2H, <i>J</i> = 8.6 Hz), 7.57 (d, 4H, <i>J</i> = 8.6 Hz), 8.35 (d, 2H, <i>J</i> = 8.6 Hz), 9.42 (s, 1H), 9.50 (s, 1H), 10.94 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 623 [M + H]. HRMS calcd for C<sub>31</sub>H<sub>33</sub>F<sub>3</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 623.2700, obsd 623.2700. HPLC purity 95%.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-(4-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-{4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl]phenyl}urea (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was prepared from <b>44</b> to give an off-white solid (HCl salt, 68% yield), according to the procedure described for 46, using 4-dimethylaminopiperidine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.61 (m, 2H), 2.04 (br, 2H), 2.72 (s, 3H), 2.74 (s, 3H), 3.43 (m, 1H), 3.78 (t, 4H, <i>J</i> = 4.5 Hz), 3.96 (t, 4H, <i>J</i> = 4.5 Hz), 5.18 (q, 2H, <i>J</i> = 8.8 Hz), 6.81 (d, 1H, <i>J</i> = 3.8 Hz), 7.33 (d, 1H, <i>J</i> = 3.8 Hz), 7.38 (d, 2H, <i>J</i> = 8.8 Hz), 7.55 (d, 2H, <i>J</i> = 8.8 Hz), 7.57 (d, 2H, <i>J</i> = 8.8 Hz), 8.35 (d, 2H, <i>J</i> = 8.8 Hz), 9.31 (s, 1H), 9.35 (s, 1H), 10.33 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 651 [M + H]. HRMS calcd for C<sub>33</sub>H<sub>37</sub>F<sub>3</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 651.3013, obsd 651.3013. HPLC purity 95%.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-(2-Chloro-7-ethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> was prepared from <b>16</b> to give an off-white solid, according to the procedure described for <b>30</b>, using iodoethane. MS (ESI): <i>m</i>/<i>z</i> 267 [M + H].</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-(7-Ethyl-4-morpholino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)aniline (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared from <b>41</b> to give an off-white solid, according to the procedure described for <b>42</b>, using 4-aminophenylboronic acid pinacol ester. MS (ESI): <i>m</i>/<i>z</i> 324 [M + H].</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-({[4-(7-Ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzoic Acid (<b>45</b>)</h3><div id="sec5_45_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Step 1</h4><div class="NLM_p last">To a solution of 4-(7-ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)aniline (<b>43</b>) (1.72 g, 5.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added methyl 4-isocyanatobenzoate (1.13 g, 6.4 mmol), and the resulting mixture was stirred at room temperature overnight. The resulting solid was collected by filtration and washed with CH<sub>2</sub>Cl<sub>2</sub> to give methyl 4-({[4-(7-ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzoate as an off-white solid (1.81 g, 68% yield). MS (ESI): <i>m</i>/<i>z</i> 501 [M + H].</div></div><div id="sec5_45_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step 2</h4><div class="NLM_p last">To a solution of methyl 4-({[4-(7-ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzoate (1.81 g, 3.6 mmol) in MeOH (50 mL) and THF (20 mL) was added 1 N NaOH aqueous solution (18 mL), and the mixture was heated at 70 °C for 3 h. The mixture was cooled to room temperature and concentrated. The residue was treated with water and acidified to pH 3−4 by addition of 1 N HCl. The resulting solid was collected by filtration, washed with water, and dried in air to give <b>45</b> as an off-white solid (1.65 g, 94% yield). MS (ESI): <i>m</i>/<i>z</i> 487 [M + H].</div></div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-[2-(Dimethylamino)ethyl]-4-({[4-(7-ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzamide (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was prepared from <b>45</b> to give an off-white solid (54% yield), according to the procedure described for <b>46</b>, using <i>N</i>,<i>N</i>-dimethylethylenediamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.40 (t, 3H, <i>J</i> = 7.3 Hz), 2.17 (s, 6H), 2.39 (t, 2H, <i>J</i> = 6.8 Hz), 3.33 (m, 2H), 3.77 (t, 4H, <i>J</i> = 4.8 Hz), 3.94 (t, 4H, <i>J</i> = 4.8 Hz), 4.27 (q, 2H, <i>J</i> = 7.3 Hz), 6.66 (d, 1H, <i>J</i> = 3.8 Hz), 7.33 (d, 1H, <i>J</i> = 3.8 Hz), 7.53 (d, 2H, <i>J</i> = 8.6 Hz), 7.56 (d, 2H, <i>J</i> = 8.6 Hz), 7.79 (d, 2H, <i>J</i> = 8.6 Hz), 8.23 (t, 1H, <i>J</i> = 5.5 Hz), 8.34 (d, 2H, <i>J</i> = 8.6 Hz), 8.98 (br, 2H). MS (ESI): <i>m</i>/<i>z</i> 557 [M + H]. HRMS calcd for C<sub>30</sub>H<sub>36</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 557.2983, obsd 557.2983. HPLC purity 98.6%.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-[4-(7-Ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]-3-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}urea (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was prepared from <b>45</b> to give an off-white solid (35% yield), according to the procedure described for <b>46</b>, using 1-methylpiperazine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.40 (t, 3H, <i>J</i> = 7.1 Hz), 2.20 (s, 3H), 2.31 (br, 4H), 3.49 (br, 4H), 3.77 (t, 4H, <i>J</i> = 5.0 Hz), 3.94 (t, 4H, <i>J</i> = 5.0 Hz), 4.27 (q, 2H, <i>J</i> = 7.1 Hz), 6.66 (d, 1H, <i>J</i> = 3.8 Hz), 7.32 (d, 1H, <i>J</i> = 3.8 Hz), 7.34 (d, 2H, <i>J</i> = 8.8 Hz), 7.53 (d, 2H, <i>J</i> = 8.8 Hz), 7.56 (d, 2H, <i>J</i> = 8.8 Hz), 8.34 (d, 2H, <i>J</i> = 8.8 Hz), 8.93 (s, 1H), 8.94 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 569 [M + H]. HRMS calcd for C<sub>31</sub>H<sub>36</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 569.2983, obsd 569.2983. HPLC purity 99.6%.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-[4-(7-Ethyl-4-morpholin-4-yl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)phenyl]-3-[4-(piperazin-1-ylcarbonyl)phenyl]urea (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was prepared from <b>45</b> to give an off-white solid (46% yield), according to the procedure described for <b>46</b>, using piperazine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.40 (t, 3H, <i>J</i> = 7.1 Hz), 2.68 (br, 4H), 3.41 (br, 4H), 3.78 (t, 4H, <i>J</i> = 5.0 Hz), 3.94 (t, 4H, <i>J</i> = 5.0 Hz), 4.27 (q, 2H, <i>J</i> = 7.1 Hz), 6.66 (d, 1H, <i>J</i> = 3.5 Hz), 7.32 (d, 1H, <i>J</i> = 3.5 Hz), 7.33 (d, 2H, <i>J</i> = 8.6 Hz), 7.53 (d, 2H, <i>J</i> = 8.6 Hz), 7.56 (d, 2H, <i>J</i> = 8.6 Hz), 8.34 (d, 2H, <i>J</i> = 8.6 Hz), 8.98 (s, 1H), 9.01 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 555 [M + H]. HRMS calcd for C<sub>30</sub>H<sub>34</sub>N<sub>8</sub>O<sub>3</sub> [M + H] 555.2827, obsd 555.2830. HPLC purity 95.2%.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zecheng Chen</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#75161d101b0f4435020c10011d5b161a1855161d101b0f10161d101b12351d1a0118141c195b161a18"><span class="__cf_email__" data-cfemail="1b78737e75612a5b6c627e6f7335787476">[email protected]</span> <span class="__cf_email__" data-cfemail="13707b767d6976707b767d74537b7c677e727a7f3d707c7e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aranapakam M. Venkatesan</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph M. Dehnhardt</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Semiramis Ayral-Kaloustian</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasja Brooijmans</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Mallon</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry Feldberg</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irwin Hollander</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judy Lucas</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ker Yu</span> - <span class="hlFld-Affiliation affiliation">Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fangming Kong</span> - <span class="hlFld-Affiliation affiliation">Analytical Quality Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek S. Mansour</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901783v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Wyeth Chemical Technologies Department for compound identification and the pharmaceutical profiling results. We also thank Dr. Derek Cole for his helpful suggestions regarding this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase-AKT pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol+3-kinase-AKT+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lhEpW9owYhOMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase-AKT%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leevers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woscholski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and function of 3-phosphorylated inositol lipids</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1146%2Fannurev.biochem.70.1.535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=11395417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVehtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=535-602&author=B.+Vanhaesebroeckauthor=S.+J.+Leeversauthor=K.+Ahmadiauthor=J.+Timmsauthor=R.+Katsoauthor=P.+C.+Driscollauthor=R.+Woscholskiauthor=P.+J.+Parkerauthor=M.+D.+Waterfield&title=Synthesis+and+function+of+3-phosphorylated+inositol+lipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and function of 3-phosphorylated inositol lipids</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Leevers, Sally J.; Ahmadi, Khatereh; Timms, John; Katso, Roy; Driscoll, Paul C.; Woscholski, Rudiger; Parker, Peter J.; Waterfield, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-602</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 443 refs.  The 3-phosphorylated inositol lipids fulfill roles as second messengers by interacting with the lipid binding domains of a variety of cellular proteins.  Such interactions can affect the subcellular localization and aggregation of target proteins, and through allosteric effects, their activity.  Generation of 3-phosphoinositides has been documented to influence diverse cellular pathways and hence alter a spectrum of fundamental cellular activities.  This review is focused on the 3-phosphoinositide lipids, the synthesis of which is acutely triggered by extracellular stimuli, the enzymes responsible for their synthesis and metab., and their cell biol. roles.  Much knowledge has recently been gained through structural insights into the lipid kinases, their interaction with inhibitors, and the way their 3-phosphoinositide products interact with protein targets.  This field is now moving toward a genetic dissection of 3-phosphoinositide action in a variety of model organisms.  Such approaches will reveal the true role of the 3-phosphoinositides at the organismal level in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpChv_q4q6cLVg90H21EOLACvtfcHk0lhEpW9owYhOMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVehtL0%253D&md5=9905473d362ef35b512d038efb901d3e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.535%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DLeevers%26aufirst%3DS.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DTimms%26aufirst%3DJ.%26aulast%3DKatso%26aufirst%3DR.%26aulast%3DDriscoll%26aufirst%3DP.%2BC.%26aulast%3DWoscholski%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DP.%2BJ.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520function%2520of%25203-phosphorylated%2520inositol%2520lipids%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D535%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leevers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayotou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-kinases: a conserved family of signal transducers</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=267-272&author=B.+Vanhaesebroeckauthor=S.+J.+Leeversauthor=G.+Panayotouauthor=M.+D.+Waterfield&title=Phosphoinositide+3-kinases%3A+a+conserved+family+of+signal+transducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DLeevers%26aufirst%3DS.%2BJ.%26aulast%3DPanayotou%26aufirst%3DG.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DPhosphoinositide%25203-kinases%253A%2520a%2520conserved%2520family%2520of%2520signal%2520transducers%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1997%26volume%3D22%26spage%3D267%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=Y.+Luauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0lgZOz5gBLeDuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0lgZOz5gBLeDuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Campbell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choong, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarella, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, W. A.</span><span> </span><span class="NLM_article-title">Mutation of the <i>PIK3CA</i> gene in ovarian and breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7678-7681&author=I.+G.+Campbellauthor=S.+E.+Russellauthor=+Davidauthor=D.+Y.+Choongauthor=K.+G.+Montgomeryauthor=M.+L.+Ciavarellaauthor=C.+S.+Hooiauthor=B.+E.+Cristianoauthor=R.+B.+Pearsonauthor=A.+Wayneauthor=W.+A.+Phillips&title=Mutation+of+the+PIK3CA+gene+in+ovarian+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26aulast%3DRussell%26aufirst%3DS.%2BE.%26aulast%3DDavid%26aulast%3DChoong%26aufirst%3DD.%2BY.%26aulast%3DMontgomery%26aufirst%3DK.%2BG.%26aulast%3DCiavarella%26aufirst%3DM.%2BL.%26aulast%3DHooi%26aufirst%3DC.%2BS.%26aulast%3DCristiano%26aufirst%3DB.%2BE.%26aulast%3DPearson%26aufirst%3DR.%2BB.%26aulast%3DWayne%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DW.%2BA.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520gene%2520in%2520ovarian%2520and%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7678%26epage%3D7681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signaling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signaling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0likfppwWITDxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520mutations%253A%2520the%2520PI3K%2520pathway%2520as%2520an%2520integrator%2520of%2520multiple%2520inputs%2520during%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">Tenets of PTEN tumor suppression</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=403-414&author=L.+Salmenaauthor=A.+Carracedoauthor=P.+P.+Pandolfi&title=Tenets+of+PTEN+tumor+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DTenets%2520of%2520PTEN%2520tumor%2520suppression%26jtitle%3DCell%26date%3D2008%26volume%3D133%26spage%3D403%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sulis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN: from pathology to biology</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1016%2FS0962-8924%2803%2900175-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=12946627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=478-483&author=M.+L.+Sulisauthor=R.+Parsons&title=PTEN%3A+from+pathology+to+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: from pathology to biology</span></div><div class="casAuthors">Sulis, Maria Luisa; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">478-483</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor gene is mutated frequently in many malignancies and its importance in the development of cancer is probably underestimated.  As the primary phosphatase of phosphatidylinositol (3,4,5)-trisphosphate, PTEN has a central role in reigning in the phosphoinositide 3-kinase (PI 3-kinase) network to control cellular homeostasis.  Cells that lack PTEN are unable to regulate the PtdIns 3-kinase program, which stimulates a variety of cellular phenotypes that favor oncogenesis.  As well as the well-known role as tumor suppressor, recent studies show that PTEN is involved in the regulation of several basic cellular functions, such as cell migration, cell size, contractility of cardiac myocytes and chemotaxis.  Here, we review the roles of PTEN in normal cellular functions and disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ltxp33aXP7Vg90H21EOLACvtfcHk0likfppwWITDxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D&md5=cd18115b50b3c634cb451c5090acda21</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900175-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900175-2%26sid%3Dliteratum%253Aachs%26aulast%3DSulis%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%253A%2520from%2520pathology%2520to%2520biology%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0likfppwWITDxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonjouklian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grindey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallegos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=7653991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2MXos1Gqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1135-1139&author=R.+M.+Schultzauthor=R.+L.+Merrimanauthor=S.+L.+Andisauthor=R.+Bonjouklianauthor=G.+B.+Grindeyauthor=P.+G.+Rutherfordauthor=A.+Gallegosauthor=K.+Masseyauthor=G.+Powis&title=In+vitro+and+in+vivo+antitumor+activity+of+the+phosphatidylinositol-3-kinase+inhibitor%2C+wortmannin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin</span></div><div class="casAuthors">Schultz, Richard M.; Merriman, Ronald L.; Andis, Sherri L.; Bonjouklian, Rosanne; Grindey, Gerald B.; Rutherford, Pamela G.; Gallegos, Alfred; Massey, Kathy; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1135-9</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">Anticancer Research</span>)
        </div><div class="casAbstract">The microbial product wortmannin has previously been shown to be a potent inhibitor of phosphatidylinositol-3-kinase.  In view of the potential role of this enzyme in transduction of mitogenic signals, we detd. the cytotoxic activity of wortmannin against several human tumor cell lines in vitro.  The most sensitive lines included GC3 colon carcinoma, IGROV1 ovarian carcinoma, and CCRF-CEM leukemia (IC-50s ranging from 0.7-2.1 μM).  The cytotoxicity of wortmannin was decreased approx. 10-fold by serum-free conditions.  Wortmannin was generally less active in low passage human breast cancer cell lines that overexpress either epidermal growth factor receptor or Her2/neu.  Wortmannin was also tested for in vivo antitumor activity against seven murine tumor and ten human tumor xenograft models.  Activity (>60% inhibition of tumor growth) was obsd. in only the C3H mammary carcinoma and the human BxPC-3 pancreatic carcinoma xenograft.  In vivo antitumor activity did not correlate with in vitro sensitivity to wortmannin cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRWOGXAAnVb7Vg90H21EOLACvtfcHk0liaWAvzSGvKIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1Gqtbw%253D&md5=3407d86b7283d2cc0a85d88380d7912e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DMerriman%26aufirst%3DR.%2BL.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DBonjouklian%26aufirst%3DR.%26aulast%3DGrindey%26aufirst%3DG.%2BB.%26aulast%3DRutherford%26aufirst%3DP.%2BG.%26aulast%3DGallegos%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DK.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activity%2520of%2520the%2520phosphatidylinositol-3-kinase%2520inhibitor%252C%2520wortmannin%26jtitle%3DAnticancer%2520Res.%26date%3D1995%26volume%3D15%26spage%3D1135%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0liaWAvzSGvKIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0liaWAvzSGvKIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Drees, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of phosphoinositide 3-kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1517%2F13543776.14.5.703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=703-732&author=B.+E.+Dreesauthor=G.+B.+Millsauthor=C.+Rommelauthor=G.+D.+Prestwich&title=Therapeutic+potential+of+phosphoinositide+3-kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of phosphoinositide 3-kinase inhibitors</span></div><div class="casAuthors">Drees, Beth E.; Mills, Gordon B.; Rommel, Christian; Prestwich, Glenn D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-732</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally discovered as oncogene-assocd. lipid kinases more than 15 yr ago, the family of phosphoinositide 3-kinase (PI 3-K) enzymes has recently emerged as an important therapeutic target in human pathophysiol.  After more than a decade with only a few inhibitors with low activity, poor isoform or kinase selectivity or unacceptable pharmacol. and toxicol. profiles, a variety of PI 3-K inhibitors with pan-isoform activity and isoform-selective inhibition have recently been identified.  A growing excitement surrounds the success of signal transduction modifiers in cancer therapy, as well as in the therapy of other diseases.  In combination with addnl. genetic evidence implicating the PI 3-K pathway in human disease, the search for more selective and more drug-like PI 3-K inhibitors has been reinvigorated.  As a consequence, many biotech and pharmaceutical companies have established PI 3-K pathway drug development programs.  With the help of important insights provided by genetic knockout animals, potential applications of PI 3-K inhibitors for the treatment of cancer, cardiovascular and endocrine disorders, autoimmune and allergic diseases and inflammation have been recognized.  Several potential drugs have now been validated in animal models of human disease but numerous pitfalls still await the translation from animal model to human clin. trials.  Herein, the progress in the development of PI 3-K inhibitors and their potential applications in medicine are summarized and the opportunities and concerns inherent in targeting this essential signaling pathway are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_ix5xLKhaLVg90H21EOLACvtfcHk0lhhmpCROWos6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFChsro%253D&md5=b081e93aa53a81e0f67adf597778bed2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.5.703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.5.703%26sid%3Dliteratum%253Aachs%26aulast%3DDrees%26aufirst%3DB.%2BE.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DTherapeutic%2520potential%2520of%2520phosphoinositide%25203-kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D703%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Norman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worzalla, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahos, C. J .</span><span> </span><span class="NLM_article-title">Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950619p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK28XpsFKhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1106-1111&author=B.+H.+Normanauthor=C+Shihauthor=J.+E.+Tothauthor=J.+E.+Rayauthor=J.+A.+Dodgeauthor=D.+W.+Johnsonauthor=P.+G.+Rutherfordauthor=R.+M.+Schultzauthor=J.+F.+Worzallaauthor=C.+J+.+Vlahos&title=Studies+on+the+mechanism+of+phosphatidylinositol+3-kinase+inhibition+by+wortmannin+and+related+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Mechanism of Phosphatidylinositol 3-Kinase Inhibition by Wortmannin and Related Analogs</span></div><div class="casAuthors">Norman, Bryan H.; Shih, Chuan; Toth, John E.; Ray, James E.; Dodge, Jeffrey A.; Johnson, Doug W.; Rutherford, Pamela G.; Schultz, Richard M.; Worzalla, John F.; Vlahos, Chris J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1106-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wortmannin, a fungal metabolite, was identified as a potent inhibitor (IC50 = 4.2 nM) of phosphatidylinositol 3-kinase (PI 3-kinase).  Due to the importance of PI 3-kinase in several intracellular signaling pathways, structure-activity studies on wortmannin analogs were performed in an effort to understand the structural requirements necessary for PI 3-kinase inhibition.  Since wortmannin is an irreversible inhibitor of PI 3-kinase, it was postulated that covalent attachment at the electrophilic C-21 site was a possible mode of action for PI 3-kinase inhibition.  The authors have prepd. various wortmannin analogs which address the possibility of this mechanism.  Of particular interest are compds. which affect the C-21 position of wortmannin either sterically or electronically.  Our results support the conclusion that nucleophilic addn. by the kinase onto the C-21 position of wortmannin is required for inhibition of PI 3-kinase by wortmannin analogs.  Addnl., we have prepd. several D-ring analogs of wortmannin, and their activities are reported herein.  The authors conclude that the wortmannin D ring is an important recognition site since modifications have such a dramatic effect on inhibitor potency.  Finally, the identification of 17β-hydroxywortmannin represents the first reported subnanomolar inhibitor of PI 3-kinase.  These studies, along with in vivo antitumor expts., suggest that the mechanism of PI 3-kinase inhibition correlates to the assocd. toxicity obsd. with wortmannin-based inhibitors of PI 3-kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiKiIYaSVQJrVg90H21EOLACvtfcHk0lhhmpCROWos6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsFKhsQ%253D%253D&md5=62f71b396d36de4fe03a63ee624753c3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm950619p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950619p%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DShih%26aufirst%3DC%26aulast%3DToth%26aufirst%3DJ.%2BE.%26aulast%3DRay%26aufirst%3DJ.%2BE.%26aulast%3DDodge%26aufirst%3DJ.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BW.%26aulast%3DRutherford%26aufirst%3DP.%2BG.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DWorzalla%26aufirst%3DJ.%2BF.%26aulast%3DVlahos%26aufirst%3DC.%2BJ%2B.%26atitle%3DStudies%2520on%2520the%2520mechanism%2520of%2520phosphatidylinositol%25203-kinase%2520inhibition%2520by%2520wortmannin%2520and%2520related%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1106%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-<i>d</i>]pyrimidine derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2438-2442&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=F.+I.+Raynaudauthor=P.+Workmanauthor=M.+D.+Waterfieldauthor=P.+Parker&title=Synthesis+and+biological+evaluation+of+pyrido%5B3%E2%80%B2%2C2%E2%80%B2%3A4%2C5%5Dfuro%5B3%2C2-d%5Dpyrimidine+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520pyrido%255B3%25E2%2580%25B2%252C2%25E2%2580%25B2%253A4%252C5%255Dfuro%255B3%252C2-d%255Dpyrimidine%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2438%26epage%3D2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol+3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0lhhmpCROWos6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol%25203-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1111%2Fj.1349-7006.2007.00580.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=17711503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=1638-1642&author=D.+Kongauthor=T.+Yamori&title=ZSTK474+is+an+ATP-competitive+inhibitor+of+class+I+phosphatidylinositol+3+kinase+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1638-1642</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Class I phosphatidylinositol 3 kinases (PI3K) phosphorylate phosphatidylinositol 4,5-bisphosphate to generate phosphatidylinositol 3,4,5-trisphosphate.  These mols. play an important role in fundamental cellular responses.  Four isoforms of class I PI3K are known to have different functions, and abnormalities in their activities have been related to various diseases such as cancer and inflammation.  We previously identified a novel PI3K inhibitor, ZSTK474, which showed potent antitumor activity in vivo against a human cancer xenograft without observable toxicity.  However, the mode of its mol. action was not investigated in detail.  Our previous study only suggested that ZSTK474 possibly competes with ATP for the ATP-binding pocket of PI3Kγ.  In the present study, we have used an in vitro homogeneous time-resolved fluorescence kinase assay to examine whether ZSTK474 is indeed an ATP-competing inhibitor of PI3K, and also to det. whether the inhibitory activity of ZSTK474 was isoform-specific.  Lineweaver-Burk plot anal. revealed that ZSTK474 inhibits all four PI3K isoforms in an ATP-competitive manner.  Among all of the PI3K isoforms, PI3Kδ was inhibited most potently by ZSTK474 with a Ki of 1.8 nM, and the other isoforms were inhibited at higher doses.  We have also used a kinase activity ELISA to det. whether ZSTK474 inhibits mammalian target of rapamycin, a key kinase acting downstream of PI3K to promote protein synthesis and cell proliferation.  Even at a concn. of 100 μM, ZSTK474 inhibited mammalian target of rapamycin activity rather weakly.  These results indicate that ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN82wpwPzvvLVg90H21EOLACvtfcHk0lgN9jBBp8lonA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI&md5=02f89fcfcdda97438724700eb3a3499a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00580.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00580.x%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DZSTK474%2520is%2520an%2520ATP-competitive%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositol%25203%2520kinase%2520isoforms%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D1638%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lgN9jBBp8lonA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Maira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lhi_CONty6knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Novel imidazolopyrimidines as dual PI3-Kinase/mTOR Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=653-656&author=A.+M.+Venkatesanauthor=C.+M.+Dehnhardtauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=B.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Novel+imidazolopyrimidines+as+dual+PI3-Kinase%2FmTOR+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DBrooijmans%26aufirst%3DB.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DNovel%2520imidazolopyrimidines%2520as%2520dual%2520PI3-Kinase%252FmTOR%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D653%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Lead optimization of N-3-substituted-7-morpholino-triazolopyrimidines as dual PI3K/mTor inhibitors: discovery of PKI-402</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=798-810&author=C.+M.+Dehnhardtauthor=A.+M.+Venkatesanauthor=E.+Delos+Santosauthor=Z.+Chenauthor=O.+Santosauthor=S.+Ayral-Kaloustianauthor=B.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Lead+optimization+of+N-3-substituted-7-morpholino-triazolopyrimidines+as+dual+PI3K%2FmTor+inhibitors%3A+discovery+of+PKI-402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9014982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014982%26sid%3Dliteratum%253Aachs%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSantos%26aufirst%3DO.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DBrooijmans%26aufirst%3DB.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DLead%2520optimization%2520of%2520N-3-substituted-7-morpholino-triazolopyrimidines%2520as%2520dual%2520PI3K%252FmTor%2520inhibitors%253A%2520discovery%2520of%2520PKI-402%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D798%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, Z.; Venkatesan, A. M.; Dehndardt, C. M.; Ayral-Kaloustian, S.; Mansour, T.; Brooijmans, N.; Mallon, R.; Hollander, I.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives as PI3-Kinase Inhibitors</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 238th National Meeting of the American Chemical Society, Washington, DC, August 16−20, 2009; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>MEDI-363.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Z.+Chen&author=A.+M.+Venkatesan&author=C.+M.+Dehndardt&author=S.+Ayral-Kaloustian&author=T.+Mansour&author=N.+Brooijmans&author=R.+Mallon&author=I.+Hollander&author=K.+Yu&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolo%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520as%2520PI3-Kinase%2520Inhibitors%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Noell, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Aromaticity in heterocyclic systems. II. The application of n.m.r. in a study of the synthesis and structure of certain imidazo[1,2-<i>c</i>]pyrimidines and related pyrrolo[2,3-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1964&pages=34-41&author=C.+W.+Noellauthor=R.+K.+Robins&title=Aromaticity+in+heterocyclic+systems.+II.+The+application+of+n.m.r.+in+a+study+of+the+synthesis+and+structure+of+certain+imidazo%5B1%2C2-c%5Dpyrimidines+and+related+pyrrolo%5B2%2C3-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoell%26aufirst%3DC.%2BW.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DAromaticity%2520in%2520heterocyclic%2520systems.%2520II.%2520The%2520application%2520of%2520n.m.r.%2520in%2520a%2520study%2520of%2520the%2520synthesis%2520and%2520structure%2520of%2520certain%2520imidazo%255B1%252C2-c%255Dpyrimidines%2520and%2520related%2520pyrrolo%255B2%252C3-d%255Dpyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1964%26volume%3D1%26spage%3D34%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Senda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives and related compounds. XXII. Synthesis and pharmacological properties of 7-deazaxanthine derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1974&pages=1459-1467&author=S.+Sendaauthor=K.+Hirota&title=Pyrimidine+derivatives+and+related+compounds.+XXII.+Synthesis+and+pharmacological+properties+of+7-deazaxanthine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenda%26aufirst%3DS.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DPyrimidine%2520derivatives%2520and%2520related%2520compounds.%2520XXII.%2520Synthesis%2520and%2520pharmacological%2520properties%2520of%25207-deazaxanthine%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1974%26volume%3D22%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">The homology model was built with Prime 1.6 ( <cite>Prime</cite>, version 1.6; Schrodinger, LLC: New York, <span class="NLM_year">2007</span>) using an in-house X-ray structure of PI3K-g in complex with a related pyrazolopyrimidine (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>.pdb) as the template. Docking studies were performed using Glide, version 4.5, initially, and version 5.5 ( <cite>Glide</cite>, version 5.5; Schrodinger, LLC: New York, <span class="NLM_year">2009</span>) more recently. Docking studies were either performed without constraints or with a hydrogen bonding constraint to the backbone-NH of Val851. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was made using PyMOL (<contrib-group>DeLano, W. L.</contrib-group> <cite>The PyMOL Molecular Graphics System</cite>; DeLano Scientific LLC: Palo Alto, CA, <span class="NLM_year">2008</span>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+homology+model+was+built+with+Prime+1.6+%28Prime%2C+version+1.6%3B+Schrodinger%2C+LLC%3A+New+York%2C+2007%29+using+an+in-house+X-ray+structure+of+PI3K-g+in+complex+with+a+related+pyrazolopyrimidine+%283IBE.pdb%29+as+the+template.+Docking+studies+were+performed+using+Glide%2C+version+4.5%2C+initially%2C+and+version+5.5+%28Glide%2C+version+5.5%3B+Schrodinger%2C+LLC%3A+New+York%2C+2009%29+more+recently.+Docking+studies+were+either+performed+without+constraints+or+with+a+hydrogen+bonding+constraint+to+the+backbone-NH+of+Val851.+Figure+2+was+made+using+PyMOL+%28DeLano%2C+W.+L.The+PyMOL+Molecular+Graphics+System%3B+DeLano+Scientific+LLC%3A+Palo+Alto%2C+CA%2C+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26btitle%3DPrime%26pub%3DSchrodinger%252C%2520LLC%26date%3D2007%26btitle%3DGlide%26pub%3DSchrodinger%252C%2520LLC%26date%3D2009%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DDeLano%2520Scientific%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Lanxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, and <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4023-4035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDimorpholine%252BSubstituted%252BThienopyrimidines%252Bas%252BPotential%252BClass%252BI%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08032017%26date%3D24042017%26date%3D11052017%26date%3D14042017%26volume%3D60%26issue%3D9%26spage%3D4023%26epage%3D4035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mijoon  Lee</span>, <span class="hlFld-ContribAuthor ">Tomas  Rucil</span>, <span class="hlFld-ContribAuthor ">Dusan  Hesek</span>, <span class="hlFld-ContribAuthor ">Allen G.  Oliver</span>, <span class="hlFld-ContribAuthor ">Jed F.  Fisher</span>, and <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Control of the SNAr Amination of 5-Substituted-2,4-Dichloropyrimidines Using Tertiary Amine Nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (15)
                                     , 7757-7763. <a href="https://doi.org/10.1021/acs.joc.5b01044" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01044%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BControl%252Bof%252Bthe%252BSNAr%252BAmination%252Bof%252B5-Substituted-2%25252C4-Dichloropyrimidines%252BUsing%252BTertiary%252BAmine%252BNucleophiles%26aulast%3DLee%26aufirst%3DMijoon%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11052015%26date%3D17072015%26date%3D07082015%26date%3D08072015%26volume%3D80%26issue%3D15%26spage%3D7757%26epage%3D7763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentine G.  Nenajdenko</span>, <span class="hlFld-ContribAuthor ">Vasiliy M.  Muzalevskiy</span>, and <span class="hlFld-ContribAuthor ">Aleksey V.  Shastin</span>  . </span><span class="cited-content_cbyCitation_article-title">Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (2)
                                     , 973-1050. <a href="https://doi.org/10.1021/cr500465n" title="DOI URL">https://doi.org/10.1021/cr500465n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500465n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500465n%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPolyfluorinated%252BEthanes%252Bas%252BVersatile%252BFluorinated%252BC2-Building%252BBlocks%252Bfor%252BOrganic%252BSynthesis%26aulast%3DNenajdenko%26aufirst%3DValentine%2BG.%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D15102013%26date%3D16012015%26date%3D28012015%26volume%3D115%26issue%3D2%26spage%3D973%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Khanfar</span> and <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>  . </span><span class="cited-content_cbyCitation_article-title">Elaborate Ligand-Based Modeling Coupled with Multiple Linear Regression and k Nearest Neighbor QSAR Analyses Unveiled New Nanomolar mTOR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (10)
                                     , 2587-2612. <a href="https://doi.org/10.1021/ci4003798" title="DOI URL">https://doi.org/10.1021/ci4003798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci4003798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci4003798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DElaborate%252BLigand-Based%252BModeling%252BCoupled%252Bwith%252BMultiple%252BLinear%252BRegression%252Band%252Bk%252BNearest%252BNeighbor%252BQSAR%252BAnalyses%252BUnveiled%252BNew%252BNanomolar%252BmTOR%252BInhibitors%26aulast%3DKhanfar%26aufirst%3DMohammad%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01072013%26date%3D04102013%26date%3D28102013%26date%3D19092013%26volume%3D53%26issue%3D10%26spage%3D2587%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noeen  Malik</span>, <span class="hlFld-ContribAuthor ">Rick  Kornelsen</span>, <span class="hlFld-ContribAuthor ">Siobhan  McCormick</span>, <span class="hlFld-ContribAuthor ">Nadine  Colpo</span>, <span class="hlFld-ContribAuthor ">Helen  Merkens</span>, <span class="hlFld-ContribAuthor ">Shreya  Bendre</span>, <span class="hlFld-ContribAuthor ">Francois  Benard</span>, <span class="hlFld-ContribAuthor ">Vesna  Sossi</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Paul  Schaffer</span>. </span><span class="cited-content_cbyCitation_article-title">Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113005. <a href="https://doi.org/10.1016/j.ejmech.2020.113005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bbiological%252Bevaluation%252Bof%25255B18F%25255DFMN3PA%252B%252526%252B%25255B18F%25255DFMN3PU%252Bfor%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bin%2525C2%2525A0vivo%252BPET%252Bimaging%26aulast%3DMalik%26aufirst%3DNoeen%26date%3D2021%26volume%3D211%26spage%3D113005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noeen  Malik</span>, <span class="hlFld-ContribAuthor ">Shreya  Bendre</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Paul  Schaffer</span>. </span><span class="cited-content_cbyCitation_article-title">Lewis Acid-Facilitated Radiofluorination of MN3PU: A LRRK2 Radiotracer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (20)
                                     , 4710. <a href="https://doi.org/10.3390/molecules25204710" title="DOI URL">https://doi.org/10.3390/molecules25204710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25204710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25204710%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DLewis%252BAcid-Facilitated%252BRadiofluorination%252Bof%252BMN3PU%25253A%252BA%252BLRRK2%252BRadiotracer%26aulast%3DMalik%26aufirst%3DNoeen%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D20%26spage%3D4710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Milcent</span>, <span class="hlFld-ContribAuthor ">Benoit  Crousse</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of
              N
              ‐
              
                CF
                2
                H
              
              ,
              N
              ‐
              
                CF
                3
              
              , and
              N
              ‐
              
                CH
                2
                CF
                3
              
              Motifs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 723-761. <a href="https://doi.org/10.1002/9783527824342.ch24" title="DOI URL">https://doi.org/10.1002/9783527824342.ch24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527824342.ch24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527824342.ch24%26sid%3Dliteratum%253Aachs%26atitle%3DConstruction%252Bof%252BN%252B%2525E2%252580%252590%252BCF%252B2%252BH%252B%25252C%252BN%252B%2525E2%252580%252590%252BCF%252B3%252B%25252C%252Band%252BN%252B%2525E2%252580%252590%252BCH%252B2%252BCF%252B3%252BMotifs%26aulast%3DMilcent%26aufirst%3DThierry%26date%3D2020%26date%3D2020%26spage%3D723%26epage%3D761%26pub%3DWiley%26atitle%3DEmerging%252BFluorinated%252BMotifs%26aulast%3DCahard%26aufirst%3DDominique%26date%3D2020%26date%3D2020%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imen  Boualia</span>, <span class="hlFld-ContribAuthor ">Chamseddine  Derabli</span>, <span class="hlFld-ContribAuthor ">Raouf  Boulcina</span>, <span class="hlFld-ContribAuthor ">Chawki  Bensouici</span>, <span class="hlFld-ContribAuthor ">Muhammet  Yildirim</span>, <span class="hlFld-ContribAuthor ">Arzu  Birinci Yildirim</span>, <span class="hlFld-ContribAuthor ">El Hassen  Mokrani</span>, <span class="hlFld-ContribAuthor ">Abdelmadjid  Debache</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4‐amino‐5‐cyanopyrimidine) derivatives. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (11)
                                     , 1900027. <a href="https://doi.org/10.1002/ardp.201900027" title="DOI URL">https://doi.org/10.1002/ardp.201900027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900027%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%252Bstudies%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Balkyl%252Bbis%2525284%2525E2%252580%252590amino%2525E2%252580%2525905%2525E2%252580%252590cyanopyrimidine%252529%252Bderivatives%26aulast%3DBoualia%26aufirst%3DImen%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D11%26spage%3D1900027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Cong  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Ren</span>, <span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Organic Chemistry</span><span> <strong>2019,</strong> <em>16 </em>
                                    (7)
                                     , 617-630. <a href="https://doi.org/10.2174/1570193X15666181029130418" title="DOI URL">https://doi.org/10.2174/1570193X15666181029130418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570193X15666181029130418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570193X15666181029130418%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Organic%2520Chemistry%26atitle%3DResearch%252BProgress%252Bof%252BDiphenyl%252BUrea%252BDerivatives%252Bas%252BAnticancer%252BAgents%252Band%252BSynthetic%252BMethodologies%26aulast%3DWu%26aufirst%3DYi-Cong%26date%3D2019%26volume%3D16%26issue%3D7%26spage%3D617%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin  Choudhary</span>, <span class="hlFld-ContribAuthor ">Anoop  Singh</span>, <span class="hlFld-ContribAuthor ">Jyothi  Yadav</span>, <span class="hlFld-ContribAuthor ">Nisar A.  Mir</span>, <span class="hlFld-ContribAuthor ">Sumati  Anthal</span>, <span class="hlFld-ContribAuthor ">Rajni  Kant</span>, <span class="hlFld-ContribAuthor ">Indresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A simple route to tetracyclic oxazepine-fused pyrroles
              via
              metal-free [3+2] annulation between dibenzo[
              b
              ,
              f
              ][1,4]oxazepines and aqueous succinaldehyde. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (2)
                                     , 953-962. <a href="https://doi.org/10.1039/C8NJ04861D" title="DOI URL">https://doi.org/10.1039/C8NJ04861D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ04861D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ04861D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DA%252Bsimple%252Broute%252Bto%252Btetracyclic%252Boxazepine-fused%252Bpyrroles%252Bvia%252Bmetal-free%252B%25255B3%25252B2%25255D%252Bannulation%252Bbetween%252Bdibenzo%25255B%252Bb%252B%25252C%252Bf%252B%25255D%25255B1%25252C4%25255Doxazepines%252Band%252Baqueous%252Bsuccinaldehyde%26aulast%3DChoudhary%26aufirst%3DSachin%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D2%26spage%3D953%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed Mujbel  Hasson</span>, <span class="hlFld-ContribAuthor ">Adil A.  Awad</span>, <span class="hlFld-ContribAuthor ">Mahmoud Najim  Al-Jibouri</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structural Investigation of Some Transition Metals Complexes of Benzimidazolium Bromide. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2019,</strong> <em>31 </em>
                                    (3)
                                     , 607-612. <a href="https://doi.org/10.14233/ajchem.2019.21641" title="DOI URL">https://doi.org/10.14233/ajchem.2019.21641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2019.21641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2019.21641%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructural%252BInvestigation%252Bof%252BSome%252BTransition%252BMetals%252BComplexes%252Bof%252BBenzimidazolium%252BBromide%26aulast%3DHasson%26aufirst%3DMohammed%2BMujbel%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D3%26spage%3D607%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ju-Hyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Ashraf K.  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Changdev G.  Gadhe</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Nakcheol  Jeong</span>, <span class="hlFld-ContribAuthor ">Soon-Sun  Hong</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (21)
                                     , 5596-5611. <a href="https://doi.org/10.1016/j.bmc.2018.10.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5%25252C6-disubstituted%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bbroad%252Bspectrum%252Bantiproliferative%252Bagents%25253A%252BSynthesis%25252C%252Bcell%252Bbased%252Bassays%25252C%252Bkinase%252Bprofile%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DLee%26aufirst%3DJu-Hyeon%26date%3D2018%26volume%3D26%26issue%3D21%26spage%3D5596%26epage%3D5611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Jakubkiene</span>, <span class="hlFld-ContribAuthor ">E.  Vaiciunaite</span>, <span class="hlFld-ContribAuthor ">K.  Kriukaite</span>, <span class="hlFld-ContribAuthor ">J.  Didzgalvis</span>, <span class="hlFld-ContribAuthor ">S.  Tumkevicius</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of novel 6-substituted 2-(4-aryl-1,2,3-triazol-1-yl)pyrimidines and 7-deazapurines. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2018,</strong> <em>48 </em>
                                    (15)
                                     , 1974-1985. <a href="https://doi.org/10.1080/00397911.2018.1474229" title="DOI URL">https://doi.org/10.1080/00397911.2018.1474229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2018.1474229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2018.1474229%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnovel%252B6-substituted%252B2-%2525284-aryl-1%25252C2%25252C3-triazol-1-yl%252529pyrimidines%252Band%252B7-deazapurines%26aulast%3DJakubkiene%26aufirst%3DV.%26date%3D2018%26date%3D2018%26volume%3D48%26issue%3D15%26spage%3D1974%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian M.  Cawrse</span>, <span class="hlFld-ContribAuthor ">Rena S.  Lapidus</span>, <span class="hlFld-ContribAuthor ">Brandon  Cooper</span>, <span class="hlFld-ContribAuthor ">Eun Yong  Choi</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Seley-Radtke</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Properties of Halogenated Pyrrolo[3,2-
              d
              ]pyrimidines with Decreased Toxicity via N5 Substitution. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (2)
                                     , 178-185. <a href="https://doi.org/10.1002/cmdc.201700641" title="DOI URL">https://doi.org/10.1002/cmdc.201700641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700641%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAnticancer%252BProperties%252Bof%252BHalogenated%252BPyrrolo%25255B3%25252C2-%252Bd%252B%25255Dpyrimidines%252Bwith%252BDecreased%252BToxicity%252Bvia%252BN5%252BSubstitution%26aulast%3DCawrse%26aufirst%3DBrian%2BM.%26date%3D2018%26date%3D2017%26volume%3D13%26issue%3D2%26spage%3D178%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanaz  Mojikhalifeh</span>, <span class="hlFld-ContribAuthor ">Alireza  Hasaninejad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,2,3,5-substituted pyrroles from α-bromoacetophenones and 2-nitroethene-1,1-diamines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (26)
                                     , 2574-2577. <a href="https://doi.org/10.1016/j.tetlet.2017.05.063" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B1%25252C2%25252C3%25252C5-substituted%252Bpyrroles%252Bfrom%252B%2525CE%2525B1-bromoacetophenones%252Band%252B2-nitroethene-1%25252C1-diamines%26aulast%3DMojikhalifeh%26aufirst%3DSanaz%26date%3D2017%26volume%3D58%26issue%3D26%26spage%3D2574%26epage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasuro  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Dwitiya B.  Sawant</span>, <span class="hlFld-ContribAuthor ">Harold A.  Fisk</span>, <span class="hlFld-ContribAuthor ">Liguang  Mao</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Somsundaram  Chettiar</span>, <span class="hlFld-ContribAuthor ">Pui-Kai  Li</span>, <span class="hlFld-ContribAuthor ">Michael V.  Darby</span>, <span class="hlFld-ContribAuthor ">Robert W.  Brueggemeier</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (7)
                                     , 2156-2166. <a href="https://doi.org/10.1016/j.bmc.2017.02.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpyrrolopyrimidines%252Bas%252BMps1%25252FTTK%252Bkinase%252Binhibitors%252Bfor%252Bbreast%252Bcancer%26aulast%3DSugimoto%26aufirst%3DYasuro%26date%3D2017%26volume%3D25%26issue%3D7%26spage%3D2156%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shun-Man  Wong</span>, <span class="hlFld-ContribAuthor ">Fuk-Yee  Kwong</span>. </span><span class="cited-content_cbyCitation_article-title">Nondirected C H Bond Functionalizations of (Hetero)arenes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 49-166. <a href="https://doi.org/10.1016/B978-0-12-805254-9.00003-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-805254-9.00003-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-805254-9.00003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-805254-9.00003-7%26sid%3Dliteratum%253Aachs%26atitle%3DNondirected%252BC%252BH%252BBond%252BFunctionalizations%252Bof%252B%252528Hetero%252529arenes%26aulast%3DWong%26aufirst%3DShun-Man%26date%3D2017%26spage%3D49%26epage%3D166%26pub%3DElsevier%26atitle%3DStrategies%252Bfor%252BPalladium-Catalyzed%252BNon-Directed%252Band%252BDirected%252BC-H%252BBond%252BFunctionalization%26date%3D2017%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatemeh  Haghighi</span>, <span class="hlFld-ContribAuthor ">Farhad  Panahi</span>, <span class="hlFld-ContribAuthor ">Mohsen  Golbon Haghighi</span>, <span class="hlFld-ContribAuthor ">Ali  Khalafi-Nezhad</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal-free
              N
              -fluoroalkylation of amines using cyanurate activated fluoroalcohols. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (94)
                                     , 12650-12653. <a href="https://doi.org/10.1039/C7CC07428J" title="DOI URL">https://doi.org/10.1039/C7CC07428J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC07428J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC07428J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTransition%252Bmetal-free%252BN%252B-fluoroalkylation%252Bof%252Bamines%252Busing%252Bcyanurate%252Bactivated%252Bfluoroalcohols%26aulast%3DHaghighi%26aufirst%3DFatemeh%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D94%26spage%3D12650%26epage%3D12653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Chenghao  Gu</span>, <span class="hlFld-ContribAuthor ">Rou  Li</span>, <span class="hlFld-ContribAuthor ">Yikai  Yu</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A green four-component synthesis of 2-amino-3-cyano-4-aryl-6-sulfanepyrimidine in water solvent using phase-transfer catalyst. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2016,</strong> <em>13 </em>
                                    (4)
                                     , 597-604. <a href="https://doi.org/10.1007/s13738-015-0770-1" title="DOI URL">https://doi.org/10.1007/s13738-015-0770-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-015-0770-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-015-0770-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DA%252Bgreen%252Bfour-component%252Bsynthesis%252Bof%252B2-amino-3-cyano-4-aryl-6-sulfanepyrimidine%252Bin%252Bwater%252Bsolvent%252Busing%252Bphase-transfer%252Bcatalyst%26aulast%3DXu%26aufirst%3DLiang%26date%3D2016%26date%3D2015%26volume%3D13%26issue%3D4%26spage%3D597%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kartik W.  Temburnikar</span>, <span class="hlFld-ContribAuthor ">Christina R.  Ross</span>, <span class="hlFld-ContribAuthor ">Gerald M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, <span class="hlFld-ContribAuthor ">Brian M.  Cawrse</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Seley-Radtke</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4354-4363. <a href="https://doi.org/10.1016/j.bmc.2015.06.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAntiproliferative%252Bactivities%252Bof%252Bhalogenated%252Bpyrrolo%25255B3%25252C2-d%25255Dpyrimidines%26aulast%3DTemburnikar%26aufirst%3DKartik%2BW.%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4354%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Bing  Chen</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>, <span class="hlFld-ContribAuthor ">An  Su</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free three-component domino reactions for regioselective synthesis of multi-functional fused pyrroles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (29)
                                     , 4745-4751. <a href="https://doi.org/10.1016/j.tet.2015.05.067" title="DOI URL">https://doi.org/10.1016/j.tet.2015.05.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.05.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.05.067%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCatalyst-free%252Bthree-component%252Bdomino%252Breactions%252Bfor%252Bregioselective%252Bsynthesis%252Bof%252Bmulti-functional%252Bfused%252Bpyrroles%26aulast%3DChen%26aufirst%3DXue-Bing%26date%3D2015%26volume%3D71%26issue%3D29%26spage%3D4745%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gheorghe  Roman</span>. </span><span class="cited-content_cbyCitation_article-title">Mannich bases in medicinal chemistry and drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 743-816. <a href="https://doi.org/10.1016/j.ejmech.2014.10.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMannich%252Bbases%252Bin%252Bmedicinal%252Bchemistry%252Band%252Bdrug%252Bdesign%26aulast%3DRoman%26aufirst%3DGheorghe%26date%3D2015%26volume%3D89%26spage%3D743%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pallabi  Saikia</span>, <span class="hlFld-ContribAuthor ">Gitarthi  Sharma</span>, <span class="hlFld-ContribAuthor ">Sanjib  Gogoi</span>, <span class="hlFld-ContribAuthor ">Romesh C.  Boruah</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade imination, Buchwald–Hartwig cross coupling and cycloaddition reaction: synthesis of pyrido[2,3-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (30)
                                     , 23210-23212. <a href="https://doi.org/10.1039/C5RA00725A" title="DOI URL">https://doi.org/10.1039/C5RA00725A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA00725A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA00725A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCascade%252Bimination%25252C%252BBuchwald%2525E2%252580%252593Hartwig%252Bcross%252Bcoupling%252Band%252Bcycloaddition%252Breaction%25253A%252Bsynthesis%252Bof%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%26aulast%3DSaikia%26aufirst%3DPallabi%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D30%26spage%3D23210%26epage%3D23212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Bing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Dan-Dan  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component domino reaction synthesis of highly functionalized bicyclic pyrrole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (5)
                                     , 1047-1054. <a href="https://doi.org/10.1016/j.tet.2013.12.062" title="DOI URL">https://doi.org/10.1016/j.tet.2013.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DThree-component%252Bdomino%252Breaction%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252Bbicyclic%252Bpyrrole%252Bderivatives%26aulast%3DChen%26aufirst%3DXue-Bing%26date%3D2014%26volume%3D70%26issue%3D5%26spage%3D1047%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jelena  Dodonova</span>, <span class="hlFld-ContribAuthor ">Sigitas  Tumkevicius</span>. </span><span class="cited-content_cbyCitation_article-title">Access to 6-arylpyrrolo[2,3-d]pyrimidines via a palladium-catalyzed direct C–H arylation reaction. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (68)
                                     , 35966-35974. <a href="https://doi.org/10.1039/C4RA07088G" title="DOI URL">https://doi.org/10.1039/C4RA07088G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA07088G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA07088G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DAccess%252Bto%252B6-arylpyrrolo%25255B2%25252C3-d%25255Dpyrimidines%252Bvia%252Ba%252Bpalladium-catalyzed%252Bdirect%252BC%2525E2%252580%252593H%252Barylation%252Breaction%26aulast%3DDodonova%26aufirst%3DJelena%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D68%26spage%3D35966%26epage%3D35974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 991-1012. <a href="https://doi.org/10.1517/17460441.2013.800479" title="DOI URL">https://doi.org/10.1517/17460441.2013.800479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.800479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.800479%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFurthering%252Bthe%252Bdesign%252Band%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252BATP-competitive%252BmTOR%252Binhibitors%252Bas%252Ban%252Beffective%252Bcancer%252Btreatment%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D991%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikita  Tolstoluzhsky</span>, <span class="hlFld-ContribAuthor ">Pavlo  Nikolaienko</span>, <span class="hlFld-ContribAuthor ">Nikolay  Gorobets</span>, <span class="hlFld-ContribAuthor ">Erik V.  Van der Eycken</span>, <span class="hlFld-ContribAuthor ">Nadezhda  Kolos</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Uracil-Derived Hexa- and Tetrahydropyrido[2,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (24)
                                     , 5364-5369. <a href="https://doi.org/10.1002/ejoc.201300683" title="DOI URL">https://doi.org/10.1002/ejoc.201300683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201300683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201300683%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEfficient%252BSynthesis%252Bof%252BUracil-Derived%252BHexa-%252Band%252BTetrahydropyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DTolstoluzhsky%26aufirst%3DNikita%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D24%26spage%3D5364%26epage%3D5369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Welker</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (14)
                                     , 4063-4091. <a href="https://doi.org/10.1016/j.bmc.2013.04.083" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bsyntheses%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DWelker%26aufirst%3DMark%2BE.%26date%3D2013%26volume%3D21%26issue%3D14%26spage%3D4063%26epage%3D4091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria L.  Pellizzaro</span>, <span class="hlFld-ContribAuthor ">Julie  Fisher</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Electronic substituent effects on hydrogen-bonding motifs modulate supramolecular polymerisation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (9)
                                     , 3103. <a href="https://doi.org/10.1039/c2ra22715k" title="DOI URL">https://doi.org/10.1039/c2ra22715k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ra22715k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ra22715k%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DElectronic%252Bsubstituent%252Beffects%252Bon%252Bhydrogen-bonding%252Bmotifs%252Bmodulate%252Bsupramolecular%252Bpolymerisation%26aulast%3DPellizzaro%26aufirst%3DMaria%2BL.%26date%3D2013%26volume%3D3%26issue%3D9%26spage%3D3103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Tumkevicius</span>, <span class="hlFld-ContribAuthor ">J.  Dodonova</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of pyrrolo[2,3-d]pyrimidine by palladium-catalyzed cross-coupling reactions (review). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2012,</strong> <em>48 </em>
                                    (2)
                                     , 258-279. <a href="https://doi.org/10.1007/s10593-012-0986-2" title="DOI URL">https://doi.org/10.1007/s10593-012-0986-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-012-0986-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-012-0986-2%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DFunctionalization%252Bof%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bby%252Bpalladium-catalyzed%252Bcross-coupling%252Breactions%252B%252528review%252529%26aulast%3DTumkevicius%26aufirst%3DS.%26date%3D2012%26date%3D2012%26volume%3D48%26issue%3D2%26spage%3D258%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Séverine  Denoyelle</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Limo  Chen</span>, <span class="hlFld-ContribAuthor ">Yibo  Wang</span>, <span class="hlFld-ContribAuthor ">Edvin  Klosi</span>, <span class="hlFld-ContribAuthor ">José A.  Halperin</span>, <span class="hlFld-ContribAuthor ">Bertal H.  Aktas</span>, <span class="hlFld-ContribAuthor ">Michael  Chorev</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro inhibition of translation initiation by N,N′-diarylureas—potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 402-409. <a href="https://doi.org/10.1016/j.bmcl.2011.10.126" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.126%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvitro%252Binhibition%252Bof%252Btranslation%252Binitiation%252Bby%252BN%25252CN%2525E2%252580%2525B2-diarylureas%2525E2%252580%252594potential%252Banti-cancer%252Bagents%26aulast%3DDenoyelle%26aufirst%3DS%25C3%25A9verine%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D402%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Aranapakam M.  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Efren  Delos-Santos</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Larry  Feldberg</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Robert  Mallon</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4773-4778. <a href="https://doi.org/10.1016/j.bmcl.2011.06.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B2-oxatriazines%252Bas%252Bhighly%252Bpotent%252Bpan-PI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DDehnhardt%26aufirst%3DChristoph%2BM.%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4773%26epage%3D4778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jo-Anne  Pinson</span>, <span class="hlFld-ContribAuthor ">Oleg  Schmidt-Kittler</span>, <span class="hlFld-ContribAuthor ">Jiuxiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Ian G.  Jennings</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Kinzler</span>, <span class="hlFld-ContribAuthor ">Bert  Vogelstein</span>, <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>, <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazolidinedione-Based PI3Kα Inhibitors: An Analysis of Biochemical and Virtual Screening Methods. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2011,</strong> <em>6 </em>
                                    (3)
                                     , 514-522. <a href="https://doi.org/10.1002/cmdc.201000467" title="DOI URL">https://doi.org/10.1002/cmdc.201000467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000467%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThiazolidinedione-Based%252BPI3K%2525CE%2525B1%252BInhibitors%25253A%252BAn%252BAnalysis%252Bof%252BBiochemical%252Band%252BVirtual%252BScreening%252BMethods%26aulast%3DPinson%26aufirst%3DJo-Anne%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3D514%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aranapakam M.  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Osvaldo Dos  Santos</span>, <span class="hlFld-ContribAuthor ">Christoph  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Efren Delos  Santos</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Robert  Mallon</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Larry  Feldberg</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Inder  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>. </span><span class="cited-content_cbyCitation_article-title">PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (19)
                                     , 5869-5873. <a href="https://doi.org/10.1016/j.bmcl.2010.07.104" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.07.104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.07.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.07.104%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPKI-179%25253A%252BAn%252Borally%252Befficacious%252Bdual%252Bphosphatidylinositol-3-kinase%252B%252528PI3K%252529%25252Fmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%252Binhibitor%26aulast%3DVenkatesan%26aufirst%3DAranapakam%2BM.%26date%3D2010%26volume%3D20%26issue%3D19%26spage%3D5869%26epage%3D5873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of PI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine (1.5 equiv), Et<sub>3</sub>N (3 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 6 h; (b) ArB(OH)<sub>2</sub> (1.5 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 110 °C/30 min, microwave; (c) DMF·DMA (excess), DMF, 110 °C/12−18 h; (d) 10% Pd/C, MeOH, room temp, 2−6 h; (e) formaldehyde (2 equiv), amines (3 equiv), HOAc, 60 °C/6 h; (f) TBSCl (1.2 equiv), imidazole (1.5 equiv), DMF, 80 °C/15 min, microwave; (g) CH<sub>3</sub>I (1.2 equiv), NaH (2 equiv), THF, room temp, 2 h; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 6 h; (i) 4-piperidone (2.5 equiv), KOH (5 equiv), MeOH, 66 °C/15 h; (j) 10% Pd/C, HCl, MeOH, 50 psi, room temp, 16 h; (k) ArCHO (1.5 equiv), ZnCl<sub>2</sub> (1.5 equiv), NaBH<sub>3</sub>CN (1.5 equiv), MeOH, room temp, 5 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, 120 °C/30 min, microwave; (b) morpholine (1.5 equiv), Et<sub>3</sub>N (3 equiv), EtOH, room temp; (c) ArB(OH)<sub>2</sub> (1.5 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 150 °C/40 min, microwave; (d) 2-(dimethylamino)ethyl chloride (1.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (3 equiv), DMF, 80 °C/12 h; (e) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 M Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (f) triphosgene (0.6 equiv), Et<sub>3</sub>N (3 equiv), amines (3−5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2−6 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (b) triphosgene (0.6 equiv), Et<sub>3</sub>N (3 equiv), 4-aminopyridine (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (c) CF<sub>3</sub>CH<sub>2</sub>I (2 equiv for <b>30</b>) or (CH<sub>3</sub>O)<sub>2</sub>CHBr (2 equiv for <b>31</b>), Cs<sub>2</sub>CO<sub>3</sub> (1.2 equiv), DMF, 80 °C/12 h; (d) HCl, dioxane/H<sub>2</sub>O, 70 °C/12 h (e) amines (6 equiv), ZnCl<sub>2</sub> (2 equiv), NaBH<sub>3</sub>CN (2 equiv), MeOH, room temp, 12 h; (f) NaBH<sub>4</sub> (1.5 equiv), MeOH/THF, room temp, 2 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-aminophenylboronic acid, pinacol ester (1.3 equiv), Pd(Ph<sub>3</sub>P)<sub>4</sub> (5 mol %), DME, 2 N Na<sub>2</sub>CO<sub>3</sub>, 130 °C/30 min, microwave; (b) methyl 4-isocyanatobenzoate (1.2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (c) 1 N NaOH (3 equiv), MeOH/THF, 70 °C/12 h; (d) amines (2 equiv), HOBt (1.5 equiv), EDCI (1.5 equiv), Et<sub>3</sub>N (2 equiv), THF, room temp, 12 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling study of <b>40</b> (shown in turquoise for its skeleton) docked in PI3Kα homology model based on PI3Kγ crystal structures.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo biomarker studies 8 h after compounds were administered at 25 mpk (iv) to MDA361 tumor bearing nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/medium/jm-2009-01783v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor efficacy of <b>46</b> in the MDA361 xenograft model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901783v/production/images/large/jm-2009-01783v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901783v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase-AKT pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol+3-kinase-AKT+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0liDmymSaozz3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase-AKT%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leevers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woscholski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and function of 3-phosphorylated inositol lipids</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1146%2Fannurev.biochem.70.1.535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=11395417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVehtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=535-602&author=B.+Vanhaesebroeckauthor=S.+J.+Leeversauthor=K.+Ahmadiauthor=J.+Timmsauthor=R.+Katsoauthor=P.+C.+Driscollauthor=R.+Woscholskiauthor=P.+J.+Parkerauthor=M.+D.+Waterfield&title=Synthesis+and+function+of+3-phosphorylated+inositol+lipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and function of 3-phosphorylated inositol lipids</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Leevers, Sally J.; Ahmadi, Khatereh; Timms, John; Katso, Roy; Driscoll, Paul C.; Woscholski, Rudiger; Parker, Peter J.; Waterfield, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-602</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 443 refs.  The 3-phosphorylated inositol lipids fulfill roles as second messengers by interacting with the lipid binding domains of a variety of cellular proteins.  Such interactions can affect the subcellular localization and aggregation of target proteins, and through allosteric effects, their activity.  Generation of 3-phosphoinositides has been documented to influence diverse cellular pathways and hence alter a spectrum of fundamental cellular activities.  This review is focused on the 3-phosphoinositide lipids, the synthesis of which is acutely triggered by extracellular stimuli, the enzymes responsible for their synthesis and metab., and their cell biol. roles.  Much knowledge has recently been gained through structural insights into the lipid kinases, their interaction with inhibitors, and the way their 3-phosphoinositide products interact with protein targets.  This field is now moving toward a genetic dissection of 3-phosphoinositide action in a variety of model organisms.  Such approaches will reveal the true role of the 3-phosphoinositides at the organismal level in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpChv_q4q6cLVg90H21EOLACvtfcHk0lgsVPUq56-h8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVehtL0%253D&md5=9905473d362ef35b512d038efb901d3e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.535%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DLeevers%26aufirst%3DS.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DTimms%26aufirst%3DJ.%26aulast%3DKatso%26aufirst%3DR.%26aulast%3DDriscoll%26aufirst%3DP.%2BC.%26aulast%3DWoscholski%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DP.%2BJ.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520function%2520of%25203-phosphorylated%2520inositol%2520lipids%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D535%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leevers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayotou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-kinases: a conserved family of signal transducers</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=267-272&author=B.+Vanhaesebroeckauthor=S.+J.+Leeversauthor=G.+Panayotouauthor=M.+D.+Waterfield&title=Phosphoinositide+3-kinases%3A+a+conserved+family+of+signal+transducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DLeevers%26aufirst%3DS.%2BJ.%26aulast%3DPanayotou%26aufirst%3DG.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DPhosphoinositide%25203-kinases%253A%2520a%2520conserved%2520family%2520of%2520signal%2520transducers%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1997%26volume%3D22%26spage%3D267%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=Y.+Luauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0lgSDMfAex52DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0lgSDMfAex52DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Campbell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choong, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarella, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooi, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, W. A.</span><span> </span><span class="NLM_article-title">Mutation of the <i>PIK3CA</i> gene in ovarian and breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7678-7681&author=I.+G.+Campbellauthor=S.+E.+Russellauthor=+Davidauthor=D.+Y.+Choongauthor=K.+G.+Montgomeryauthor=M.+L.+Ciavarellaauthor=C.+S.+Hooiauthor=B.+E.+Cristianoauthor=R.+B.+Pearsonauthor=A.+Wayneauthor=W.+A.+Phillips&title=Mutation+of+the+PIK3CA+gene+in+ovarian+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26aulast%3DRussell%26aufirst%3DS.%2BE.%26aulast%3DDavid%26aulast%3DChoong%26aufirst%3DD.%2BY.%26aulast%3DMontgomery%26aufirst%3DK.%2BG.%26aulast%3DCiavarella%26aufirst%3DM.%2BL.%26aulast%3DHooi%26aufirst%3DC.%2BS.%26aulast%3DCristiano%26aufirst%3DB.%2BE.%26aulast%3DPearson%26aufirst%3DR.%2BB.%26aulast%3DWayne%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DW.%2BA.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520gene%2520in%2520ovarian%2520and%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7678%26epage%3D7681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signaling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signaling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0lg1IohBLty31Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520mutations%253A%2520the%2520PI3K%2520pathway%2520as%2520an%2520integrator%2520of%2520multiple%2520inputs%2520during%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">Tenets of PTEN tumor suppression</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=403-414&author=L.+Salmenaauthor=A.+Carracedoauthor=P.+P.+Pandolfi&title=Tenets+of+PTEN+tumor+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DTenets%2520of%2520PTEN%2520tumor%2520suppression%26jtitle%3DCell%26date%3D2008%26volume%3D133%26spage%3D403%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sulis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN: from pathology to biology</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1016%2FS0962-8924%2803%2900175-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=12946627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=478-483&author=M.+L.+Sulisauthor=R.+Parsons&title=PTEN%3A+from+pathology+to+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: from pathology to biology</span></div><div class="casAuthors">Sulis, Maria Luisa; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">478-483</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor gene is mutated frequently in many malignancies and its importance in the development of cancer is probably underestimated.  As the primary phosphatase of phosphatidylinositol (3,4,5)-trisphosphate, PTEN has a central role in reigning in the phosphoinositide 3-kinase (PI 3-kinase) network to control cellular homeostasis.  Cells that lack PTEN are unable to regulate the PtdIns 3-kinase program, which stimulates a variety of cellular phenotypes that favor oncogenesis.  As well as the well-known role as tumor suppressor, recent studies show that PTEN is involved in the regulation of several basic cellular functions, such as cell migration, cell size, contractility of cardiac myocytes and chemotaxis.  Here, we review the roles of PTEN in normal cellular functions and disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ltxp33aXP7Vg90H21EOLACvtfcHk0lgcmR3BkKD6oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D&md5=cd18115b50b3c634cb451c5090acda21</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900175-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900175-2%26sid%3Dliteratum%253Aachs%26aulast%3DSulis%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%253A%2520from%2520pathology%2520to%2520biology%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0ljGcnC7UsVcog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonjouklian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grindey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallegos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=7653991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2MXos1Gqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1135-1139&author=R.+M.+Schultzauthor=R.+L.+Merrimanauthor=S.+L.+Andisauthor=R.+Bonjouklianauthor=G.+B.+Grindeyauthor=P.+G.+Rutherfordauthor=A.+Gallegosauthor=K.+Masseyauthor=G.+Powis&title=In+vitro+and+in+vivo+antitumor+activity+of+the+phosphatidylinositol-3-kinase+inhibitor%2C+wortmannin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin</span></div><div class="casAuthors">Schultz, Richard M.; Merriman, Ronald L.; Andis, Sherri L.; Bonjouklian, Rosanne; Grindey, Gerald B.; Rutherford, Pamela G.; Gallegos, Alfred; Massey, Kathy; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1135-9</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">Anticancer Research</span>)
        </div><div class="casAbstract">The microbial product wortmannin has previously been shown to be a potent inhibitor of phosphatidylinositol-3-kinase.  In view of the potential role of this enzyme in transduction of mitogenic signals, we detd. the cytotoxic activity of wortmannin against several human tumor cell lines in vitro.  The most sensitive lines included GC3 colon carcinoma, IGROV1 ovarian carcinoma, and CCRF-CEM leukemia (IC-50s ranging from 0.7-2.1 μM).  The cytotoxicity of wortmannin was decreased approx. 10-fold by serum-free conditions.  Wortmannin was generally less active in low passage human breast cancer cell lines that overexpress either epidermal growth factor receptor or Her2/neu.  Wortmannin was also tested for in vivo antitumor activity against seven murine tumor and ten human tumor xenograft models.  Activity (>60% inhibition of tumor growth) was obsd. in only the C3H mammary carcinoma and the human BxPC-3 pancreatic carcinoma xenograft.  In vivo antitumor activity did not correlate with in vitro sensitivity to wortmannin cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRWOGXAAnVb7Vg90H21EOLACvtfcHk0ljGcnC7UsVcog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1Gqtbw%253D&md5=3407d86b7283d2cc0a85d88380d7912e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DMerriman%26aufirst%3DR.%2BL.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DBonjouklian%26aufirst%3DR.%26aulast%3DGrindey%26aufirst%3DG.%2BB.%26aulast%3DRutherford%26aufirst%3DP.%2BG.%26aulast%3DGallegos%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DK.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activity%2520of%2520the%2520phosphatidylinositol-3-kinase%2520inhibitor%252C%2520wortmannin%26jtitle%3DAnticancer%2520Res.%26date%3D1995%26volume%3D15%26spage%3D1135%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lhSYt9I9aBV0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hennessy, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span> </span><span class="NLM_article-title">Exploiting the PI3K/AKT pathway for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1038%2Fnrd1902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16341064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=988-1004&author=B.+T.+Hennessyauthor=D.+L.+Smithauthor=P.+T.+Ramauthor=Y.+Luauthor=G.+B.+Mills&title=Exploiting+the+PI3K%2FAKT+pathway+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery</span></div><div class="casAuthors">Hennessy, Bryan T.; Smith, Debra L.; Ram, Prahlad T.; Lu, Yiling; Mills, Gordon B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">988-1004</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evolving studies with several different targeted therapeutic agents are demonstrating that patients with genomic alterations of the target, including amplification, translocation and mutation, are more likely to respond to the therapy.  Recent studies indicate that numerous components of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway are targeted by amplification, mutation and translocation more frequently than any other pathway in cancer patients, with resultant activation of the pathway.  This warrants exploiting the PI3K/AKT pathway for cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq40Fg-hLrrMbVg90H21EOLACvtfcHk0lhSYt9I9aBV0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbjI&md5=faecabc3a6799137d133afb37d139ceb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd1902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1902%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRam%26aufirst%3DP.%2BT.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26atitle%3DExploiting%2520the%2520PI3K%252FAKT%2520pathway%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D988%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Drees, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of phosphoinositide 3-kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1517%2F13543776.14.5.703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFChsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=703-732&author=B.+E.+Dreesauthor=G.+B.+Millsauthor=C.+Rommelauthor=G.+D.+Prestwich&title=Therapeutic+potential+of+phosphoinositide+3-kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of phosphoinositide 3-kinase inhibitors</span></div><div class="casAuthors">Drees, Beth E.; Mills, Gordon B.; Rommel, Christian; Prestwich, Glenn D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-732</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Originally discovered as oncogene-assocd. lipid kinases more than 15 yr ago, the family of phosphoinositide 3-kinase (PI 3-K) enzymes has recently emerged as an important therapeutic target in human pathophysiol.  After more than a decade with only a few inhibitors with low activity, poor isoform or kinase selectivity or unacceptable pharmacol. and toxicol. profiles, a variety of PI 3-K inhibitors with pan-isoform activity and isoform-selective inhibition have recently been identified.  A growing excitement surrounds the success of signal transduction modifiers in cancer therapy, as well as in the therapy of other diseases.  In combination with addnl. genetic evidence implicating the PI 3-K pathway in human disease, the search for more selective and more drug-like PI 3-K inhibitors has been reinvigorated.  As a consequence, many biotech and pharmaceutical companies have established PI 3-K pathway drug development programs.  With the help of important insights provided by genetic knockout animals, potential applications of PI 3-K inhibitors for the treatment of cancer, cardiovascular and endocrine disorders, autoimmune and allergic diseases and inflammation have been recognized.  Several potential drugs have now been validated in animal models of human disease but numerous pitfalls still await the translation from animal model to human clin. trials.  Herein, the progress in the development of PI 3-K inhibitors and their potential applications in medicine are summarized and the opportunities and concerns inherent in targeting this essential signaling pathway are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_ix5xLKhaLVg90H21EOLACvtfcHk0lhTo1UG67lDiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFChsro%253D&md5=b081e93aa53a81e0f67adf597778bed2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.5.703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.5.703%26sid%3Dliteratum%253Aachs%26aulast%3DDrees%26aufirst%3DB.%2BE.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26atitle%3DTherapeutic%2520potential%2520of%2520phosphoinositide%25203-kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D703%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Norman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worzalla, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahos, C. J .</span><span> </span><span class="NLM_article-title">Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950619p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADyaK28XpsFKhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1106-1111&author=B.+H.+Normanauthor=C+Shihauthor=J.+E.+Tothauthor=J.+E.+Rayauthor=J.+A.+Dodgeauthor=D.+W.+Johnsonauthor=P.+G.+Rutherfordauthor=R.+M.+Schultzauthor=J.+F.+Worzallaauthor=C.+J+.+Vlahos&title=Studies+on+the+mechanism+of+phosphatidylinositol+3-kinase+inhibition+by+wortmannin+and+related+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Mechanism of Phosphatidylinositol 3-Kinase Inhibition by Wortmannin and Related Analogs</span></div><div class="casAuthors">Norman, Bryan H.; Shih, Chuan; Toth, John E.; Ray, James E.; Dodge, Jeffrey A.; Johnson, Doug W.; Rutherford, Pamela G.; Schultz, Richard M.; Worzalla, John F.; Vlahos, Chris J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1106-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wortmannin, a fungal metabolite, was identified as a potent inhibitor (IC50 = 4.2 nM) of phosphatidylinositol 3-kinase (PI 3-kinase).  Due to the importance of PI 3-kinase in several intracellular signaling pathways, structure-activity studies on wortmannin analogs were performed in an effort to understand the structural requirements necessary for PI 3-kinase inhibition.  Since wortmannin is an irreversible inhibitor of PI 3-kinase, it was postulated that covalent attachment at the electrophilic C-21 site was a possible mode of action for PI 3-kinase inhibition.  The authors have prepd. various wortmannin analogs which address the possibility of this mechanism.  Of particular interest are compds. which affect the C-21 position of wortmannin either sterically or electronically.  Our results support the conclusion that nucleophilic addn. by the kinase onto the C-21 position of wortmannin is required for inhibition of PI 3-kinase by wortmannin analogs.  Addnl., we have prepd. several D-ring analogs of wortmannin, and their activities are reported herein.  The authors conclude that the wortmannin D ring is an important recognition site since modifications have such a dramatic effect on inhibitor potency.  Finally, the identification of 17β-hydroxywortmannin represents the first reported subnanomolar inhibitor of PI 3-kinase.  These studies, along with in vivo antitumor expts., suggest that the mechanism of PI 3-kinase inhibition correlates to the assocd. toxicity obsd. with wortmannin-based inhibitors of PI 3-kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiKiIYaSVQJrVg90H21EOLACvtfcHk0lhTo1UG67lDiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsFKhsQ%253D%253D&md5=62f71b396d36de4fe03a63ee624753c3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm950619p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950619p%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DShih%26aufirst%3DC%26aulast%3DToth%26aufirst%3DJ.%2BE.%26aulast%3DRay%26aufirst%3DJ.%2BE.%26aulast%3DDodge%26aufirst%3DJ.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BW.%26aulast%3DRutherford%26aufirst%3DP.%2BG.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DWorzalla%26aufirst%3DJ.%2BF.%26aulast%3DVlahos%26aufirst%3DC.%2BJ%2B.%26atitle%3DStudies%2520on%2520the%2520mechanism%2520of%2520phosphatidylinositol%25203-kinase%2520inhibition%2520by%2520wortmannin%2520and%2520related%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1106%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-<i>d</i>]pyrimidine derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2438</span><span class="NLM_x">–</span> <span class="NLM_lpage">2442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2438-2442&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=F.+I.+Raynaudauthor=P.+Workmanauthor=M.+D.+Waterfieldauthor=P.+Parker&title=Synthesis+and+biological+evaluation+of+pyrido%5B3%E2%80%B2%2C2%E2%80%B2%3A4%2C5%5Dfuro%5B3%2C2-d%5Dpyrimidine+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520pyrido%255B3%25E2%2580%25B2%252C2%25E2%2580%25B2%253A4%252C5%255Dfuro%255B3%252C2-d%255Dpyrimidine%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2438%26epage%3D2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yaguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1093%2Fjnci%2Fdjj133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=16622124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=545-556&author=S.+Yaguchiauthor=Y.+Fukuiauthor=I.+Koshimizuauthor=H.+Yoshimiauthor=T.+Matsunoauthor=H.+Goudaauthor=S.+Hironoauthor=K.+Yamazakiauthor=T.+Yamori&title=Antitumor+activity+of+ZSTK474%2C+a+new+phosphatidylinositol+3-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor</span></div><div class="casAuthors">Yaguchi, Shin-ichi; Fukui, Yasuhisa; Koshimizu, Ichiro; Yoshimi, Hisashi; Matsuno, Toshiyuki; Gouda, Hiroaki; Hirono, Shuichi; Yamazaki, Kanami; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: We previously synthesized a novel s-triazine deriv., ZSTK474 [2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine], that strongly inhibited the growth of tumor cells.  We identified its mol. target, investigated its effects on cellular signaling pathways, and examd. its antitumor efficacy and toxicity in vivo.  Methods: We used COMPARE anal. of chemosensitivity measurements from 39 human cancer cell lines and identified phosphatidylinositol 3-kinase (PI3K) as a mol. target for ZSTK474.  PI3K was immunopptd. from A549 cell lysates, and its activity was measured by assessing the incorporation of 32P into phosphatidylinositol.  We used the crystal structure of the PI3K-LY294002 complex to model the binding of ZSTK474 to PI3K (where LY294002 is a known PI3K inhibitor).  PI3K downstream activity was analyzed by immunoblotting.  Antitumor activity of ZSTK474 was examd. against A549, PC-3, and WiDr xenografts in nude mice.  Phosphorylation of Akt, a serine/threonine protein kinase and a major signaling component downstream of PI3K, was assessed in vivo by immunohistochem.  Results: PI3K was identified as a mol. target for ZSTK474 by COMPARE anal.  We confirmed that ZSTK474 directly inhibited PI3K activity more efficiently than the PI3K inhibitor LY294002.  At concns. of 1 μM, ZSTK474 and LY2194002 reduced PI3K activity to 4.7% (95% confidence interval [CI] = 3.2% to 6.1%) and 44.6% (95% CI = 38.9% to 50.3%), resp., of the untreated control level.  Mol. modeling of the PI3K-ZSTK474 complex indicated that ZSTK474 could bind to the ATP-binding pocket of PI3K.  ZSTK474 inhibited phosphorylation of signaling components downstream from PI3K, such as Akt and glycogen synthase kinase 3β, and mediated a decrease in cyclin D1 levels.  ZSTK474 administered orally to mice had strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  Akt phosphorylation was reduced in xenograft tumors after oral administration of ZSTK474.  Conclusion: ZSTK474 is a new PI3K inhibitor with strong antitumor activity against human cancer xenografts without toxic effects in crit. organs.  ZSTK474 merits further investigation as an anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG0v8LFKdruLVg90H21EOLACvtfcHk0lhTo1UG67lDiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOjsLw%253D&md5=a2593024975536089ab2ee7e53234ebc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj133%26sid%3Dliteratum%253Aachs%26aulast%3DYaguchi%26aufirst%3DS.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DKoshimizu%26aufirst%3DI.%26aulast%3DYoshimi%26aufirst%3DH.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520ZSTK474%252C%2520a%2520new%2520phosphatidylinositol%25203-kinase%2520inhibitor%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1111%2Fj.1349-7006.2007.00580.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=17711503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2007&pages=1638-1642&author=D.+Kongauthor=T.+Yamori&title=ZSTK474+is+an+ATP-competitive+inhibitor+of+class+I+phosphatidylinositol+3+kinase+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1638-1642</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Class I phosphatidylinositol 3 kinases (PI3K) phosphorylate phosphatidylinositol 4,5-bisphosphate to generate phosphatidylinositol 3,4,5-trisphosphate.  These mols. play an important role in fundamental cellular responses.  Four isoforms of class I PI3K are known to have different functions, and abnormalities in their activities have been related to various diseases such as cancer and inflammation.  We previously identified a novel PI3K inhibitor, ZSTK474, which showed potent antitumor activity in vivo against a human cancer xenograft without observable toxicity.  However, the mode of its mol. action was not investigated in detail.  Our previous study only suggested that ZSTK474 possibly competes with ATP for the ATP-binding pocket of PI3Kγ.  In the present study, we have used an in vitro homogeneous time-resolved fluorescence kinase assay to examine whether ZSTK474 is indeed an ATP-competing inhibitor of PI3K, and also to det. whether the inhibitory activity of ZSTK474 was isoform-specific.  Lineweaver-Burk plot anal. revealed that ZSTK474 inhibits all four PI3K isoforms in an ATP-competitive manner.  Among all of the PI3K isoforms, PI3Kδ was inhibited most potently by ZSTK474 with a Ki of 1.8 nM, and the other isoforms were inhibited at higher doses.  We have also used a kinase activity ELISA to det. whether ZSTK474 inhibits mammalian target of rapamycin, a key kinase acting downstream of PI3K to promote protein synthesis and cell proliferation.  Even at a concn. of 100 μM, ZSTK474 inhibited mammalian target of rapamycin activity rather weakly.  These results indicate that ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN82wpwPzvvLVg90H21EOLACvtfcHk0lhRHfURGVCczA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qtbzI&md5=02f89fcfcdda97438724700eb3a3499a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00580.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00580.x%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DZSTK474%2520is%2520an%2520ATP-competitive%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositol%25203%2520kinase%2520isoforms%26jtitle%3DCancer%2520Sci.%26date%3D2007%26volume%3D98%26spage%3D1638%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lhRHfURGVCczA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maira, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Imidazo[4,5-<i>c</i>]quinolines as inhibitors of the PI3K/PKB-pathway</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1027-1030&author=F.+Staufferauthor=S.+M.+Mairaauthor=P.+Furetauthor=C.+Garcia-Echeverria&title=Imidazo%5B4%2C5-c%5Dquinolines+as+inhibitors+of+the+PI3K%2FPKB-pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DImidazo%255B4%252C5-c%255Dquinolines%2520as%2520inhibitors%2520of%2520the%2520PI3K%252FPKB-pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Maira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901783v&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901783v&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901783v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0ljRTD5q4No6lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Novel imidazolopyrimidines as dual PI3-Kinase/mTOR Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=653-656&author=A.+M.+Venkatesanauthor=C.+M.+Dehnhardtauthor=Z.+Chenauthor=E.+Delos+Santosauthor=O.+Santosauthor=M.+Bursavichauthor=A.+M.+Gilbertauthor=J.+W.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=B.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Novel+imidazolopyrimidines+as+dual+PI3-Kinase%2FmTOR+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DSantos%26aufirst%3DO.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DBrooijmans%26aufirst%3DB.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DNovel%2520imidazolopyrimidines%2520as%2520dual%2520PI3-Kinase%252FmTOR%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D653%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Dehnhardt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Lead optimization of N-3-substituted-7-morpholino-triazolopyrimidines as dual PI3K/mTor inhibitors: discovery of PKI-402</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=798-810&author=C.+M.+Dehnhardtauthor=A.+M.+Venkatesanauthor=E.+Delos+Santosauthor=Z.+Chenauthor=O.+Santosauthor=S.+Ayral-Kaloustianauthor=B.+Brooijmansauthor=R.+Mallonauthor=I.+Hollanderauthor=L.+Feldbergauthor=J.+Lucasauthor=K.+Yuauthor=J.+Gibbonsauthor=R.+Abrahamauthor=T.+S.+Mansour&title=Lead+optimization+of+N-3-substituted-7-morpholino-triazolopyrimidines+as+dual+PI3K%2FmTor+inhibitors%3A+discovery+of+PKI-402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9014982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014982%26sid%3Dliteratum%253Aachs%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSantos%26aufirst%3DO.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DBrooijmans%26aufirst%3DB.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DLead%2520optimization%2520of%2520N-3-substituted-7-morpholino-triazolopyrimidines%2520as%2520dual%2520PI3K%252FmTor%2520inhibitors%253A%2520discovery%2520of%2520PKI-402%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D798%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, Z.; Venkatesan, A. M.; Dehndardt, C. M.; Ayral-Kaloustian, S.; Mansour, T.; Brooijmans, N.; Mallon, R.; Hollander, I.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives as PI3-Kinase Inhibitors</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 238th National Meeting of the American Chemical Society, Washington, DC, August 16−20, 2009; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>MEDI-363.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Z.+Chen&author=A.+M.+Venkatesan&author=C.+M.+Dehndardt&author=S.+Ayral-Kaloustian&author=T.+Mansour&author=N.+Brooijmans&author=R.+Mallon&author=I.+Hollander&author=K.+Yu&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolo%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520as%2520PI3-Kinase%2520Inhibitors%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Noell, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Aromaticity in heterocyclic systems. II. The application of n.m.r. in a study of the synthesis and structure of certain imidazo[1,2-<i>c</i>]pyrimidines and related pyrrolo[2,3-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1964&pages=34-41&author=C.+W.+Noellauthor=R.+K.+Robins&title=Aromaticity+in+heterocyclic+systems.+II.+The+application+of+n.m.r.+in+a+study+of+the+synthesis+and+structure+of+certain+imidazo%5B1%2C2-c%5Dpyrimidines+and+related+pyrrolo%5B2%2C3-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoell%26aufirst%3DC.%2BW.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DAromaticity%2520in%2520heterocyclic%2520systems.%2520II.%2520The%2520application%2520of%2520n.m.r.%2520in%2520a%2520study%2520of%2520the%2520synthesis%2520and%2520structure%2520of%2520certain%2520imidazo%255B1%252C2-c%255Dpyrimidines%2520and%2520related%2520pyrrolo%255B2%252C3-d%255Dpyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1964%26volume%3D1%26spage%3D34%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Senda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives and related compounds. XXII. Synthesis and pharmacological properties of 7-deazaxanthine derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1974&pages=1459-1467&author=S.+Sendaauthor=K.+Hirota&title=Pyrimidine+derivatives+and+related+compounds.+XXII.+Synthesis+and+pharmacological+properties+of+7-deazaxanthine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSenda%26aufirst%3DS.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DPyrimidine%2520derivatives%2520and%2520related%2520compounds.%2520XXII.%2520Synthesis%2520and%2520pharmacological%2520properties%2520of%25207-deazaxanthine%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1974%26volume%3D22%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">The homology model was built with Prime 1.6 ( <cite>Prime</cite>, version 1.6; Schrodinger, LLC: New York, <span class="NLM_year">2007</span>) using an in-house X-ray structure of PI3K-g in complex with a related pyrazolopyrimidine (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>.pdb) as the template. Docking studies were performed using Glide, version 4.5, initially, and version 5.5 ( <cite>Glide</cite>, version 5.5; Schrodinger, LLC: New York, <span class="NLM_year">2009</span>) more recently. Docking studies were either performed without constraints or with a hydrogen bonding constraint to the backbone-NH of Val851. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was made using PyMOL (<contrib-group>DeLano, W. L.</contrib-group> <cite>The PyMOL Molecular Graphics System</cite>; DeLano Scientific LLC: Palo Alto, CA, <span class="NLM_year">2008</span>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+homology+model+was+built+with+Prime+1.6+%28Prime%2C+version+1.6%3B+Schrodinger%2C+LLC%3A+New+York%2C+2007%29+using+an+in-house+X-ray+structure+of+PI3K-g+in+complex+with+a+related+pyrazolopyrimidine+%283IBE.pdb%29+as+the+template.+Docking+studies+were+performed+using+Glide%2C+version+4.5%2C+initially%2C+and+version+5.5+%28Glide%2C+version+5.5%3B+Schrodinger%2C+LLC%3A+New+York%2C+2009%29+more+recently.+Docking+studies+were+either+performed+without+constraints+or+with+a+hydrogen+bonding+constraint+to+the+backbone-NH+of+Val851.+Figure+2+was+made+using+PyMOL+%28DeLano%2C+W.+L.The+PyMOL+Molecular+Graphics+System%3B+DeLano+Scientific+LLC%3A+Palo+Alto%2C+CA%2C+2008%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26btitle%3DPrime%26pub%3DSchrodinger%252C%2520LLC%26date%3D2007%26btitle%3DGlide%26pub%3DSchrodinger%252C%2520LLC%26date%3D2009%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DDeLano%2520Scientific%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901783v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm901783v%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901783v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994a6c2a6724eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
